intz20200630

0001437749-20-017830.txt : 20200813 0001437749-20-017830.hdr.sgml : 20200813 20200813163518 ACCESSION NUMBER: 0001437749-20-017830 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200813 DATE AS OF CHANGE: 20200813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INTRUSION INC CENTRAL INDEX KEY: 0000736012 STANDARD INDUSTRIAL CLASSIFICATION: COMPUTER COMMUNICATIONS EQUIPMENT [3576] IRS NUMBER: 751911917 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-20191 FILM NUMBER: 201099823 BUSINESS ADDRESS: STREET 1: 1101 ARAPAHO ROAD CITY: RICHARDSON STATE: TX ZIP: 75081 BUSINESS PHONE: 9722346400 MAIL ADDRESS: STREET 1: 1101 ARAPAHO ROAD CITY: RICHARDSON STATE: TX ZIP: 75081 FORMER COMPANY: FORMER CONFORMED NAME: INTRUSION COM INC DATE OF NAME CHANGE: 20000601 FORMER COMPANY: FORMER CONFORMED NAME: ODS NETWORKS INC DATE OF NAME CHANGE: 19970507 FORMER COMPANY: FORMER CONFORMED NAME: OPTICAL DATA SYSTEMS INC DATE OF NAME CHANGE: 19950517 10-Q 1 intz20200630_10q.htm FORM 10-Q intz20200630_10q.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

OR

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 0-20191

INTRUSION INC.

(Exact name of registrant as specified in its charter)

Delaware	75-1911917
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1101 East Arapaho Road, Suite 200, Richardson, Texas 75081

(Address of principal executive offices)

(Zip Code)

(972) 234-6400

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

* * * * * * * * * *

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

The number of shares outstanding of the Registrant’s Common Stock, $0.01 par value, on July 31, 2020 was 13,792,030.

INTRUSION INC.

INDEX

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements

Unaudited Condensed Consolidated Balance Sheets as of June 30, 2020 and December 31, 2019	3

Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2020 and 2019	4

Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity for the six months ended June 30, 2020 and 2019	5

Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2020 and 2019	6

Notes to Unaudited Condensed Consolidated Financial Statements	7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	13

Item 4. Controls and Procedures	16

PART II – OTHER INFORMATION	16

Item 1. Legal Proceedings	16

Item 1A. Risk Factors	17

Item 6. Exhibits	19

Signature Page	20

PART I – FINANCIAL INFORMATION

Item 1. FINANCIAL STATEMENTS

INTRUSION INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value amounts)

	June 30, 2020			December 31, 2019
ASSETS
Current Assets:
Cash and cash equivalents	$	2,872		$	3,334
Accounts receivable		1,067			1,566
Prepaid expenses		388			152
Total current assets		4,327			5,052
Noncurrent Assets:
Property and equipment, net		311			335
Finance leases, right-of-use assets, net		41			62
Operating leases, right-of-use asset, net		1,223			1,348
Other assets		36			38
Total noncurrent assets		1,611			1,783
TOTAL ASSETS	$	5,938		$	6,835

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities:
Accounts payable and accrued expenses	$	1,152		$	1,080
Dividends payable		19			20
Finance leases liability, current portion		38			43
Operating leases liability, current portion		291			284
PPP loan payable, current portion		285			—
Deferred revenue		164			516
Total current liabilities		1,949			1,943
Noncurrent Liabilities:
Finance leases liability, noncurrent portion		5			21
Operating leases liability, noncurrent portion		1,170			1,315
PPP loan payable, noncurrent portion		345			—
Total noncurrent liabilities		1,520			1,336

Commitments and contingencies

Stockholders’ equity:
Preferred stock, $0.01 par value: Authorized shares – 5,000
Series 1 shares issued and outstanding — 200 Liquidation preference of $1,012 in 2020 and $1,013 in 2019		707			707
Series 2 shares issued and outstanding — 420 in 2020 and 460 in 2019 Liquidation preference of $1,054 in 2020 and $1,155 in 2019		661			724
Series 3 shares issued and outstanding — 266 in 2020 and 289 in 2019 Liquidation preference of $583 in 2020 and $634 in 2019		379			412
Common stock, $0.01 par value:
Authorized shares — 80,000
Issued shares — 13,802 in 2020 and 13,552 in 2019 Outstanding shares — 13,792 in 2020 and 13,542 in 2019		138			136
Common stock held in treasury, at cost – 10 shares		(362	)		(362	)
Additional paid-in capital		56,946			56,759
Accumulated deficit		(55,957	)		(54,777	)
Accumulated other comprehensive loss		(43	)		(43	)
Total stockholders’ equity		2,469			3,556
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	5,938		$	6,835

See accompanying notes.

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)

	Three Months Ended						Six Months Ended
	June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019
Revenue	$	1,655		$	4,020		$	3,450		$	7,211
Cost of revenue		651			1,590			1,398			2,874

Gross profit		1,004			2,430			2,052			4,337

Operating expenses:
Sales and marketing		485			46			995			458
Research and development		907			296			1,660			477
General and administrative		326			321			582			652

Operating income (loss)		(714	)		1,767			(1,185	)		2,750

Interest income		1			—			7			—
Interest expense		(2	)		(9	)		(2	)		(44	)

Net income (loss)	$	(715	)	$	1,758		$	(1,180	)	$	2,706

Preferred stock dividends accrued		(33	)		(35	)		(66	)		(69	)
Net income (loss) attributable to common stockholders	$	(748	)	$	1,723		$	(1,246	)	$	2,637

Net income (loss) per share attributable to common stockholders:
Basic	$	(0.05	)	$	0.13		$	(0.09	)	$	0.20
Diluted	$	(0.05	)	$	0.11		$	(0.09	)	$	0.17

Weighted average common shares outstanding:
Basic		13,784			13,523			13,743			13,466
Diluted		13,784			15,371			13,743			15,314

See accompanying notes.

INTRUSION INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(In thousands)

	Six Months Ended
	June 30, 2020			June 30, 2019
NUMBER OF PREFERRED SHARES—ISSUED AND OUTSTANDING
Balance, beginning of quarter		949			949
Conversion of preferred stock to common		(63	)		—
Balance, end of quarter		886			949
PREFERRED STOCK
Balance, beginning of quarter	$	1,843		$	1,843
Conversion of preferred stock to common		(96	)		—
Balance, end of quarter		1,747			1,843
NUMBER OF COMMON SHARES—ISSUED
Balance, beginning of quarter		13,552			13,259
Conversion of preferred stock to common		63			—
Exercise of stock options		187			280
Balance, end of quarter		13,802			13,539
COMMON STOCK
Balance, beginning of quarter	$	136		$	133
Conversion of preferred stock to common		1			—
Exercise of stock options		1			2
Balance, end of quarter	$	138		$	135
TREASURY SHARES
Balance, beginning of quarter and end of quarter	$	(362	)	$	(362	)
ADDITIONAL PAID-IN-CAPITAL
Balance, beginning of quarter	$	56,759		$	56,609
Conversion of preferred stock to common		95			—
Stock-based compensation		74			14
Exercise of stock options		84			224
Preferred stock dividends declared, net of waived penalties by shareholders		(66	)		(62	)
Balance, end of quarter	$	56,946		$	56,785
ACCUMULATED DEFICIT
Balance, beginning of quarter	$	(54,777	)	$	(59,242	)
Net income (loss)		(1,180	)		2,706
Balance, end of quarter	$	(55,957	)	$	(56,536	)
ACCUMULATED OTHER COMPREHENSIVE LOSS
Balance, beginning of quarter and end of quarter	$	(43	)	$	(43	)
TOTAL STOCKHOLDERS’ EQUITY	$	2,469		$	1,822

See accompanying notes.

INTRUSION INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

	Six Months Ended
	June 30, 2020			June 30, 2019
Operating Activities:
Net income (loss)	$	(1,180	)	$	2,706
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization		107			86
Stock-based compensation		74			14
Penalties on dividends		—			6
Noncash lease costs		124			304
Changes in operating assets and liabilities:
Accounts receivable		499			(738	)
Prepaid expenses and other assets		(234	)		(234	)
Accounts payable and accrued expenses		(64	)		(66	)
Deferred revenue		(352	)		179
Net cash provided by (used in) operating activities		(1,026	)		2,257

Investing Activities:
Purchases of property and equipment		(62	)		(168	)

Financing Activities:
Proceeds from PPP loan payable		629			—
Payments on loan from officer		—			(1,815	)
Proceeds from stock options exercised		85			226
Payments of dividends		(67	)		(644	)
Reduction of finance lease liability		(21	)		(31	)
Net cash provided by (used in) financing activities		626			(2,264	)

Net decrease in cash and cash equivalents		(462	)		(175	)
Cash and cash equivalents at beginning of period		3,334			1,652
Cash and cash equivalents at end of period	$	2,872		$	1,477


SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:

Preferred stock dividends accrued	$	66		$	68
Conversion of preferred stock to common	$	96		$	—

See accompanying notes.

INTRUSION INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.	Description of Business

We develop, market and support a family of entity identification, high speed data mining and cybersecurity solutions. Our products help detect, report and mitigate cybercrimes and advanced persistent threats.

Our product families include:

●

TraceCop for entity identification, cybercrime detection and disclosure, and;

●

Savant for high speed data mining, analytics, detection, reporting and mitigation of cybersecurity threats.

Our products in development include:

●

Intrusion Shield

We are in the process of developing a new product offering, Intrusion Shield, that is designed to be a next generation intrusion detection and protection solution. After 20 years of providing research, analysis, and tools to the federal government and enterprise corporations, Intrusion possesses a comprehensive and proprietary database of Internet activity, including information about the activities of malicious online actors. Intrusion’s Shield product will combine that comprehensive database with artificial intelligence (AI) and real-time process flow technology to provide businesses and government agencies with a unique and affordable tool to detect, identify, and prevent cyber-crimes.

Shield is a combination of plug-and-play hardware, software, global data, and AI services providing organizations with aggressive protection against unaddressed information security threats and the most robust defense possible against cybercrime. Unlike traditional industry approaches that rely heavily on human resources, which malicious actors have learned to bypass, Intrusion Shield uses our extensive database together with real-time AI technology to prevent illicit behavior. Shield's proprietary architecture isolates and neutralizes malicious traffic and network flows that existing solutions cannot identify or even characterize. Most breaches today are caused by malware free compromises that trigger no alarms in a firewall or endpoint solution. The common denominator is network communications, and Shield monitors and analyses all network traffic and communications allowing it to identify and stop malware-free attacks. Shield's capabilities will continuously evolve based on real-time updates originating from our worldwide installations and growing TraceCop database identifying new dangers.

Shield does not seek to displace existing solutions, instead providing a new, and additional layer of cybersecurity for enterprises. According to SBA 2019, the U.S. enterprise market consists of 30.7 million businesses, of which 70% are characterized as small and medium sized businesses. While the company believes that many large enterprises will recognize the need this product addresses and will be incentivized to purchase Shield, the enterprise market has many decision makers for new security product purchases; therefore, the sale cycle may be longer for this product than our current product offerings. We have identified businesses with from 100 to 1,000 users as our initial target market, as we believe this market segment has the most pressing need for the enhanced protection that the Intrusion Shield will offer. We intend to leverage existing and new channel partners, such as value added resellers and systems integrators, to market Shield to this target market.

Shield has experienced positive progress during Alpha testing and the Company has identified twelve companies for the Beta release anticipated to begin in September. The configuration of hardware is a single Dell network appliance installed inline inside of the customer's firewall. The size of the network appliance will vary depending on the number of workstations and the size of the customer's internet connection be that 1Gb, 10Gb, or 100 Gb.

Intrusion’s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.

We market and distribute our products through a direct sales force to:

	●	end-users, and
	●	value-added resellers.

Our end-user customers include:

●

U.S. federal government entities,

●

state and local government entities,

●

large and diverse conglomerates,

●

manufacturing entities, and

●

other customers.

We were organized in Texas in September 1983 and reincorporated in Delaware in October 1995. Our principal executive offices are located at 1101 East Arapaho Road, Suite 200, Richardson, Texas 75081, and our telephone number is (972) 234-6400. Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. Trademarks of Intrusion include:

●

INTRUSION SHIELD

●

PROCESS FLOW TECHNOLOGY

●

INTRUSION SAVANT

●

BRINGING SCIENCE INTO DECISION MAKING

●

TRACECOP

●

INTRUSION PROTECT EVERYTHING. TRUST NOTHING

●

PROTECT EVERYTHING. TRUST NOTHING.

2. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Item 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2019 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three and six month periods ended June 30, 2020 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10-K for the year ended December 31, 2019, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 27, 2020.

The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do not bear market rates of interest. Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.

On January 1, 2019 we adopted ASU No. 2016-02, Leases (topic 842). At the date of adoption there was no impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU No. 2016-02 did not have a material effect on the Company’s results of operations or cash flows for the three and six month periods ended June 30, 2020 and 2019.

3. Loan Payable to Officer

On February 8, 2018, the Company entered into an unsecured revolving promissory note to borrow up to $3,700,000 from G. Ward Paxton. Under the terms of the CEO Note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $3,700,000 at any given time through March 2020.

On February 7, 2019, the Company amended the unsecured revolving promissory note to borrow up to $2,700,000 from G. Ward Paxton, the Company’s former Chief Executive Officer. Amounts borrowed under the CEO Note accrued interest at a floating rate per annum equal to Silicon Valley Bank’s (“SVB”) prime rate plus 1%. Under the terms of the note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,700,000 at any given time through March 2021. We reduced our borrowing under this note to zero as of May 2019.

As of October 24, 2019, G. Ward Paxton passed away, terminating the CEO Note with the result that future borrowings thereunder will no longer be available to the Company. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms are acceptable to the Company, if at all.

4. Accounting for Stock-Based Compensation

During the three month periods ended June 30, 2020 and 2019, the Company granted 323,000 and 24,000, respectively, of stock options to employees or directors. The Company recognized $55,000 and $10,000, respectively, of stock-based compensation expense for the three month periods ended June 30, 2020 and 2019. During the six month periods ended June 30, 2020 and 2019, the Company granted 323,000 and 24,000, respectively, of stock options to employees and directors. The Company recognized $74,000 and $14,000, respectively, of stock-based compensation expense for the six month periods ended June 30, 2020 and 2019.

During the three month periods ended June 30, 2020 and 2019, 14,000 and 14,000 were exercised under the 2005 Plan, respectively. During the six month periods ended June 30, 2020 and 2019, 186,600 and 280,500 were exercised under the 2005 Plan, respectively.

Valuation Assumptions

The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

	For Three Months Ended June 30, 2020			For Three Months Ended June 30, 2019			For Six Months Ended June 30, 2020			For Six Months Ended June 30, 2019

Weighted average grant date fair value	$	2.80		$	3.61		$	2.80		$	3.61
Weighted average assumptions used:
Expected dividend yield		0.0	%		0.0	%		0.0	%		0.0	%
Risk-free interest rate		0.43	%		2.19	%		0.43	%		2.19	%
Expected volatility		76.00	%		127.52	%		76.00	%		127.52	%
Expected life (in years)		6.2			5.0			6.2			5.0

Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award. Options granted to non-employees are valued using the fair market value on each measurement date of the option.

5. Revenue Recognition

We generally recognize product revenue upon shipment or after meeting certain performance obligations. These products can include hardware, perpetual software licenses and data sets. Data set updates are the majority of our sales. We do not currently offer software on a subscription basis. Warranty costs and sales returns have not been material.

We recognize sales of our data sets in accordance with FASB ASC Topic 606 whereby revenue from contracts with

customers is not recognized until all five of the following have been met:

identify the contract with a customer;

ii)

identify the performance obligations in the contract;

iii)

determine the transaction price;

	iv)	allocate the transaction price to the separate performance obligations; and
	v)	recognize revenue upon satisfaction of a performance obligation.

Data updates are typically done monthly and revenue will be matched accordingly. Product sales may include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We may defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally one year.

Service revenue, primarily including maintenance, training and installation are recognized upon delivery of the service and typically are unrelated to product sales. To date, training and installation revenue has not been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.

Our normal payment terms offered to customers, distributors and resellers are net 30 days domestically and net 45 days internationally. We do not offer payment terms that extend beyond one year and rarely do we extend payment terms beyond our normal terms. If certain customers do not meet our credit standards, we do require payment in advance to limit our credit exposure.

Shipping and handling costs are billed to the customer and included in product revenue. Shipping and handling expenses are included in cost of product revenue. We have elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.

Contract assets represent contract billings for sales per contracts with customers and are classified as current. Our contract assets include our accounts receivables. At June 30, 2020, the Company had contract assets balance of $1,067,000. At December 31, 2019, the Company had contract assets balance of $1,566,000.

Contract liabilities consist of cash payments in advance of the Company satisfying performance obligations and recognizing revenue. The Company currently classifies deferred revenue as a contract liability. At June 30, 2020, the Company had contract liabilities balance of $164,000. At December 31, 2019, the Company had contract liabilities balance of $516,000.

6. Net Income (Loss) Per Share

Basic net income (loss) per share is computed by dividing net income attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. Our common stock equivalents include all common stock issuable upon conversion of preferred stock and the exercise of outstanding options. The aggregate number of common stock equivalents excluded from the diluted income (loss) per share calculation for the three month periods ended June 30, 2020 and 2019 are 1,942,990 and 12,132, respectively. The aggregate number of common stock equivalents excluded from the diluted income (loss) per share calculation for the six month periods ended June 30, 2020 and 2019 are 1,909,289 and 6,066, respectively. Since the Company is in a net loss position for the three and six month periods ending June 30, 2020, basic and dilutive net loss per share are the same.

7. Concentrations

Our operations are concentrated in one area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 91.0% of total revenues for the second quarter of 2020 compared to 91.3% of total revenues for the second quarter of 2019. During the second quarter of 2020, approximately 91.0% of total revenues were attributable to four government customers compared to approximately 73.2% of total revenues attributable to three government customers in the second quarter of 2019. In the second quarter of 2020, no individual commercial customer had revenues over 10.0% of total revenue compared to no individual commercial customer for the same period in 2019. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.

8. Commitments and Contingencies

We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise in the future will not have such a material impact on the Company.

9. Dividends Payable

During the quarter ended June 30, 2020, we accrued $13,000 in dividends payable to the holders of our 5% Preferred Stock, $13,000 in dividends payable to the holders of our Series 2 5% Preferred Stock and $7,000 in dividends payable to the holders of our Series 3 5% Preferred Stock. As of June 30, 2020, we had $19,000 in accrued and unpaid dividends, all of which have been paid as of the date of this Quarterly Report.

10. Right-of-use Asset and Leasing Liabilities

Under the new lease accounting standard, we have determined that we have leases for right-of-use (ROU) assets. We have both finance right-of-use assets and operating right-of-use assets with a related lease liability. Our finance lease right-of-use assets consist of computer hardware and a copying machine. Our operating lease right-of-use assets include our rental agreements for our offices in Richardson and San Marcos, CA. Both types of lease liabilities are determined by the net present value of total payments and are amortized over the life of the lease. Both types of lease obligations are designed to terminate with the last scheduled payment. All of the finance lease right-of-use assets have a three year life and are in various stages of completion. The Richardson operating lease liability has a life of four years and five months as of June 30, 2020. The San Marcos operating lease liability has a life of nine months as of June 30, 2020. The adoption of the lease accounting standard resulted in the recognition of an operating ROU asset of $1,553 thousand and a related lease liability of $1,744 thousand during the first quarter of 2019.

Additional qualitative and quantitative disclosures regarding the Company's leasing arrangements are also required. The Company adopted ASC 842 prospectively and elected the package of transition practical expedients that does not require reassessment of: (1) whether any existing or expired contracts are or contain leases, (2) lease classification and (3) initial direct costs. In addition, the Company has elected other available practical expedients to not separate lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of 12 months or less.

As the implicit rate is not readily determinable for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates SVB's prime rate.

Supplemental cash flow information includes operating cash flows related to operating leases. For the six months ended June 30, 2020 and 2019, the Company had $179 thousand and $88 thousand, respectively, in operating cash flows related to operating leases.

Schedule of Items Appearing on the Statement of Operations:

	Three Months Ended				Six Months Ended
	June 30, 2020		June 30, 2019		June 30, 2020		June 30, 2019
Operating expense:
Amortization expense – Finance ROU	$	11	$	16	$	21	$	32
Lease expense – Operating ROU		82		83		165		162
Other expense:
Interest expense – Finance ROU	$	—	$	1	$	1	$	2

Future minimum lease obligations consisted of the following at June 30, 2020 (in thousands):

	Operating			Finance
Period ending June 30,	ROU Leases			ROU Leases			Total
2021	$	363		$	39		$	402
2022		363			5			368
2023		375			—			375
2024		384			—			384
2025		159			—			159
Thereafter		—			—			—
	$	1,644		$	44		$	1,688
Less Interest*		(183	)		(1	)
	$	1,461		$	43

*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.

11. PPP Loan

On March 27, 2020, the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which includes provision for a Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration (“SBA”). The PPP allows qualifying businesses to borrow up to $10 million calculated based on qualifying payroll costs. The loan is guaranteed by the federal government, and does not require collateral. On April 30, 2020 we entered into a PPP Loan with Silicon Valley Bank effective April 30, 2020, pursuant to the PPP under CARES for $629,000. The PPP Loan matures on April 30, 2022 and bears interest at a rate of 1.0% per annum. Monthly amortized principal and interest payments are deferred for six months after the date of disbursement. The PPP Loan funds were received on April 30, 2020. The PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP provides that (1) the use of PPP Loan amount shall be limited to certain qualifying expenses, (2) 100 percent of the principal amount of the loan is guaranteed by the SBA and (3) an amount up to the full principal amount may qualify for loan forgiveness in accordance with the terms of CARES. We are not yet able to determine the amount that might be forgiven. As of June 30, 2020, the Company was in full compliance with all covenants with respect to the PPP Loan. The Company expects to use the full proceeds of the PPP loan in accordance with the provisions of CARES. As of June 30, 2020, the balance of the PPP Loan was $630,000, which includes $1.0 thousand in accrued interest.

Future minimum loan obligations consisted of the following at June 30, 2020 (in thousands):

Period ending June 30,	PPP Loan
2021	$	285
2022		356
2023		—
2024		—
2025		—
Thereafter		—
	$	641
Less Interest*		(11	)
	$	630

12. Coronavirus Outbreak in the United States

Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of federal government entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results. The extent of the impact of COVID-19 on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers, employees and vendors all of which are uncertain and cannot be predicted. A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and may require additional cost and effort should our employees not be able to be physically on-premises.

13. Subsequent Events.

As of the date of this Quarterly Report, all current shares of issued and outstanding preferred stock have been voluntarily converted, resulting in the issuance of a total of 1,004,249 newly issued shares of the Company’s common stock. The addition of these newly issued shares has resulted in the dilution of each share of issued and outstanding common stock by a factor of 7.28%. While the elimination of these three classes of preferred stock removes a number of the Company’s obligations to the holders of preferred stock (such as the obligation to pay continuing dividends) as well as a number of restrictions on the Company’s activities (such as restrictions on certain capital raising and funding transactions), the addition of these newly issued shares combined with the fact that the Company’s common stock is thinly traded on the OTCQB Marketplace could cause an increase in selling volume, and result in a decline in the market price of the Company’s common stock.

On August 6, 2020, Anthony J. LeVecchio was appointed to the board of directors and to serve on the Company’s audit and compensation committees.

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This Quarterly Report on Form 10-Q, including, without limitation, the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements are generally accompanied by words such as “estimate,” “expect,” “believe,” “should,” “would,” “could,” “anticipate,” “may” or other words that convey uncertainty of future events or outcomes. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations, which we describe in more detail elsewhere in this Quarterly Report on Form 10-Q, as well as in our 2019 Annual Report on Form 10-K, filed March 27, 2020, in Item 1A “Risk Factors” include, but are not limited to:

●

the uncertain ramifications related to the coronavirus outbreak;

●

our ability to successfully create, market, sell and distribute our new Shield product to a new and distinct customer base

●

our ability to produce and promote our new commercial product, Intrusion Shield, and market it through new sales channels to a new set of prospective customers;

●

insufficient cash to operate our business and inability to meet our liquidity requirements;

●

loss of revenues due to the failure of our newer products, Shield in particular, to achieve market acceptance;

●

our need to increase current revenue levels in order to achieve sustainable profitability;

●

our unavailability to make future borrowings under the CEO Note;

●

our ability to replace all or a portion of the borrowing capacity available to the Company under the CEO Note and whether any such terms would be available on terms acceptable to the Company, if at all;

●

our ability to raise funds through debt or equity offerings related to launching a commercial product;

●

concentration of our revenues from U.S. government entities or commercial customers and the possibility of loss of one of these customers and the unique risks associated with government customers;

●

our dependence on sales made through indirect channels; and

●

the influence that our management and larger stockholders have over actions taken by the Company.

If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary significantly from what we projected. These forward-looking statements and other statements made elsewhere in this report are made in reliance on the Private Securities Litigation Reform Act of 1995. Any forward-looking statement you read in this Quarterly Report on Form 10-Q or our Annual Report on Form 10-K reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The section below entitled “Factors That May Affect Future Results of Operations” sets forth and incorporates by reference certain factors that could cause actual future results of the Company to differ materially from these statements.

Results of Operations

The following table sets forth, for the periods indicated, certain financial data as a percentage of net revenues. The period-to-period comparison of financial results is not necessarily indicative of future results.

	Three Months Ended						Six Months Ended
	June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019
Total revenue		100.0	%		100.0	%		100.0	%		100.0	%

Total cost of revenue		39.3			39.6			40.5			39.9

Gross profit		60.7			60.4			59.5			60.1

Operating expenses:
Sales and marketing		29.3			1.0			28.8			6.3
Research and development		54.8			7.4			48.1			6.7
General and administrative	19.7				8.0			16.9			9.0
Operating income (loss)		(43.1	)		43.9			(34.3	)		38.1

Interest income		0.1			—			0.2			—
Interest expense		(0.2	)		(0.2	)		(0.1	)		(0.6	)

Income (loss) before income tax provision		(43.2	)		43.7			(34.2	)		37.5

Income tax provision		—			—			—			—

Net income (loss)		(43.2	)%		43.7	%		(34.2	)%		37.5	%
Preferred stock dividends accrued		(2.0	)		(0.8	)		(1.9	)		(0.9	)

Net income (loss) attributable to common stockholders		(45.2	)%		42.9	%		(36.1	)%		36.6	%

	Three Months Ended						Six Months Ended
	June 30, 2020			June 30, 2019			June 30, 2020			June 30, 2019
Domestic revenues		100.0	%		100.0	%		100.0	%		100.0	%
Export revenues		—			—			—			—

Net revenues		100.0	%		100.0	%		100.0	%		100.0	%

Net Revenues. Net revenues for the quarter and six months ended June 30, 2020 were $1.7 million and $3.5 million, respectively, compared to $4.0 million and $7.2 million for the same periods in 2019. Product revenues decreased $2.3 million for the quarter ended June 30, 2020, and $3.7 million for the six months ended June 30, 2020 compared to the same periods in 2019. Decreased product revenues were primarily due to a decrease in sales of our TraceCop product line. TraceCop sales for the quarters ended June 30, 2020 and 2019 were $1.6 million and $4.0 million, respectively. Savant sales were $106 thousand for the quarter ended June 30, 2020 and were $29 thousand for the quarter ended June 30, 2019.

Concentration of Revenues. Revenues from sales to various U.S. government entities totaled $1.5 million, or 91.0% of revenues, for the quarter ended June 30, 2020 compared to $3.9 million, or 91.3% of revenues, for the same period in 2019. Revenues from sales to various U.S. government entities totaled $2.8 million, or 80.8% of revenues, for the six months ended June 30, 2020 compared to $6.4 million, or 89.2% of revenues, for the same period in 2019. Sales to commercial customers totaled 9.0% of total revenue for the second quarter of 2020 compared to 8.7% of total revenue for the second quarter of 2019. During the second quarter of 2020 and 2019, no individual commercial customer had revenues over 10.0% of total revenue. Although we expect our concentration of revenues to vary among customers in future periods depending upon the timing of certain sales, we anticipate that sales to government customers will continue to account for a significant portion of our revenues in future periods. Sales to the government present risks in addition to those involved in sales to commercial customers which could adversely affect our revenues, including, without limitation, potential disruption to appropriation and spending patterns and the government’s reservation of the right to cancel contracts and purchase orders for its convenience. Although we do not anticipate that any of our revenues with government customers will be renegotiated, a large number of cancelled or renegotiated government orders could have a material adverse effect on our financial results. Currently, we are not aware of any proposed cancellation or renegotiation of any of our existing arrangements with government entities and, historically, government entities have not cancelled or renegotiated orders which had a material adverse effect on our business.

Gross Profit. Gross profit was $1.0 million or 60.7% of net revenues for the quarter ended June 30, 2020, compared to $2.4 million or 60.4% of net revenues for the quarter ended June 30, 2019. Gross profit was $2.1 million or 59.5% of net revenues for the six months ended June 30, 2020 compared to $4.3 million or 60.1% of net revenues for the six months ended June 30, 2019. Gross profit on product revenues trended from 59.5% of net revenues for the six months ended June 30, 2020 to 60.1% of net revenues for the six months ended June 30, 2019, mainly due to TraceCop/Savant product mix. Gross profit as a percentage of net revenues is impacted by several factors, including shifts in product mix, changes in channels of distribution, revenue volume, pricing strategies, and fluctuations in revenues of integrated third-party products.

Sales and Marketing. Sales and marketing expenses increased to $0.5 million for the quarter ended June 30, 2020 compared to $46 thousand for the same period in 2019. Sales and marketing expenses increased to $1.0 million for the six months ended June 30, 2020 compared to $0.5 million for the same period in 2019. Sales and marketing expenses may vary in the future. Sales and marketing expenses increased compared to the comparable periods last year due to increases in labor and expenses and the Company was able to collect payment of $200 thousand from a customer related expense in 2018 that reduced expense in 2019. We believe that these costs will increase through the end of 2020 due to increased marketing expense related to the Shield launch.

Research and Development. Research and development expenses increased to $0.9 million for the quarter ended June 30, 2020 compared to $0.3 million for the same period in 2019. Research and development expenses increased to $1.7 million for the six months ended June 30, 2020 compared to $0.5 million for the same period in 2019. The increase in research and development expense was due partly to increased costs related to the development of our Intrusion Shield product as well as an increase in labor expense due to less direct labor required on existing projects. Research and development costs are expensed in the period in which they are incurred. Research and development expenses may vary in the future; mainly dependent on levels of research and development labor expense charged to projects.

General and Administrative. General and administrative expenses remained constant at $0.3 million for the quarters ended June 30, 2020 and 2019. General and administrative expenses decreased to $0.6 million for the six months ended June 30, 2020 compared to $0.7 million for the same period in 2019. It is expected that general and administrative expenses will remain relatively constant throughout the remainder of 2020, although expenses may be increased due to increased expenses related to a new product launch.

Interest. Interest expense decreased to $2 thousand for the quarter ended June 30, 2020 compared to $9 thousand for the same period in 2019. Interest expense decreased to $2 thousand for the six months ended June 30, 2020 compared to $44 thousand for the same period in 2019. Interest expense decreased due to decreased amount of Loan Payable to Officer culminating in our repayment of the balance in May 2019. Interest expense will vary in the future based on our cash flow and borrowing needs. Interest income increased to $1 thousand for the quarter ended June 30, 2020 compared to none for the same period in 2019. Interest income increased to $7 thousand for the six months ended June 30, 2020 compared to none for the same period in 2019. This is attributable to investing extra cash in money market accounts and getting better interest rates.

Liquidity and Capital Resources

Our principal source of liquidity at June 30, 2020 was approximately $2.9 million of cash and cash equivalents. At June 30, 2020, we had working capital of $2.4 million compared to $1.4 million at June 30, 2019.

Net cash used in operations for the six months ended June 30, 2020 was $1.0 million due primarily to a net loss of $1.2 million and the following uses of cash: a $352 thousand decrease in deferred revenue, a $234 thousand increase in prepaid expenses and other assets, and a $64 thousand decrease in accounts payable and accrued expenses. This was partially offset by the following provisions of cash and non-cash items: a $499 thousand decrease in accounts receivable, $124 thousand in noncash lease costs, $107 thousand in depreciation and amortization expense, and $74 thousand in stock-based compensation. Net cash provided by operations for the six months ended June 30, 2019 was $2.3 million due primarily to a net income of $2.7 million and the following provisions of cash and non-cash items: $304 thousand in noncash lease costs, a $179 thousand increase in deferred revenue, $86 thousand in depreciation and amortization expense, $14 thousand in stock-based compensation, and $6 thousand in penalties and waived penalties on dividends. This was partially offset by a $738 thousand increase in accounts receivable, a $234 thousand increase in prepaid expenses and other assets, and a $66 thousand decrease in accounts payable and accrued expenses. Future fluctuations in accounts receivable and accounts payable will be dependent upon several factors, including, but not limited to, quarterly sales volumes and timing of invoicing, and the accuracy of our forecasts of product demand and component requirements.

Net cash used in investing activities for the six months ended June 30, 2020, was $62 thousand for net purchases of property and equipment, compared to $168 thousand net cash used in investing activities for the six months ended June 30, 2019 for net purchases of property and equipment.

Net cash provided by financing activities in 2020 was $0.6 million generated primarily by proceeds from a PPP loan of $0.6 million and proceeds from exercise of stock options of $85 thousand. This was directly offset by the following uses of cash: payments for preferred stock dividends of $67 thousand, and payment on principal of finance right-of-use leases of $21 thousand. Net cash used in financing activities in 2019 was $2.3 million with payments on the loan from an officer of $1.8 million, payments for preferred stock dividends of $644 thousand, and payment on principal of finance right-of-use leases of $31 thousand. This was directly offset by the following provisions of cash: proceeds from exercise of stock options of $226 thousand.

At June 30, 2020, the Company did not have any material commitments for capital expenditures.

During the six months ended June 30, 2020, the Company funded its operations through the use of cash and cash equivalents. As of June 30, 2020, we had cash and cash equivalents of approximately $2,872,000, down from approximately $3,334,000 as of December 31, 2019. We had a net loss of $715,000 for the quarter ended June 30, 2020 compared to a net income of $1,758,000 for the quarter ended June 30, 2019. Based on projections of growth in revenue in the coming quarters, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months.

As of October 24, 2019, our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms are available on terms acceptable to the Company, if at all (the “Potential Replacement Funding Facility”).

We expect to fund our operations through anticipated Company profits, the Potential Replacement Funding Facility, and possible additional investments of equity and debt. Any equity or debt options, if available at all, may be on terms which are not favorable to us and, in the case of any potential equity financings, may result in dilution to our stockholders. If our operations do not generate positive cash flow in the future, or if we are not able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we may be unable to implement our business plan, fund our liquidity needs or even continue our operations.

Item 4.

CONTROLS AND PROCEDURES

We maintain “disclosure controls and procedures,” as defined in Rule 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance of achieving the desired control objectives, and we necessarily are required to apply our judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

Our management, including our principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2020, and concluded that the disclosure controls and procedures were effective.

Our management, with the participation of our principal executive officer and principal financial officer, evaluated our “internal control over financial reporting” (as defined in Rule 13a-15(f) under the Exchange Act) as of December 31, 2019, and concluded that there have not been any changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

Item 1.

LEGAL PROCEEDINGS

We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise will not have such a material impact in the future.

Item 1A. RISK FACTORS

Factors That May Affect Future Results of Operations

We are providing the following information regarding changes that have occurred to previously disclosed risk factors from our Annual Report on Form 10-K for the year ended December 31, 2019. In addition to the other information set forth below and elsewhere in this report, you should consider the factors discussed under the heading “Risk Factors” in our Form 10-K for the year ended December 31, 2019 filed on March 27, 2020 and in our Form 10-Q for the quarter ended March 31, 2020 filed on May 15, 2020. The risks described in our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of the federal, state, and local governmental entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results.

We have a concentration of customers that are federal, state, and local governmental entities. Such entities will be required to allocate resources and adjust budgets to accommodate potential contingencies related to the effects of the coronavirus and measures required to be put in place to prevent and contain contamination of the virus. These uncertainties have resulted in certain of our customers delaying budgeted expenditures or re-allocating resources that would result in a decrease in orders from these customers, and the possibility that other customers may follow suit in the weeks and months to come. Any such decrease in orders from these customers could cause a material adverse effect on our operations and financial results.

A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and may require additional cost and effort should our employees not be able to be physically on-premises.

Should we experience periods where it is not prudent for some or all of our employees to be physically present on-site, we may not have the benefit of the time and skills of such employees or we may be required to adjust our current business operations and processes to permit some or all of our employees at any one of our locations to work remotely in order to avoid the potential spread of the virus. We can offer no assurances that these adjustments would not cause material disruptions to our daily operations, require us to expend our time, energy and resources to make necessary adjustments, and may result in a material adverse effect on our sales, research and development and other critical areas of our business model.

Our common stock may experience volatility in trading or loss in value as a result of the effects of the coronavirus on the US and global economies.

Uncertainties surrounding the effects of the coronavirus on the US and global economies has resulted in an increase in volatility and violent drops in the value of publicly traded securities, including the trading in our common stock. We can offer no assurances that these effects are temporary or that any losses that are incurred as a result of these uncertainties will be regained if and when this crisis has passed. As a result, the value of our stock remains subject to such volatility and potential loss of market value.

We may be unable to successfully produce and promote our new commercial product, Intrusion Shield, and market it through new sales channels to a new set of prospective customers.

We anticipate significant resources will be required in order to complete product development of Intrusion Shield, including the time, attention, and focus of our senior management and our research and development team, coordination of new marketing strategies highlighting this new product offering and promoting it through new and expanded sales channels to a wider audience of prospective customers than we have historically marketed and sold our products and services. In addition, significant financial resources will be required to successfully manage and implementation this new product rollout. This could result in diversion of those resources from critical areas of our company operations and a potential strain on our liquidity and ability to meet our current and these anticipated increases in our cash-flow needs. We may need to explore possible funding sources in order to successfully complete this project, including, without limitation, exploring options for meeting those needs through equity investment and/or debt financing which may not be on terms favorable to the Company and its stockholders (if available at all), and in the instance where additional equity securities may be issued, result in significant dilution to our existing stockholders.

We could experience damage to our reputation in the cyber-security industry in the event that our Intrusion Shield product fails to perform as expected, to meet our customers’ needs, or to achieve market acceptance.

Our reputation in the industry as a leading provider of entity identification, data mining, and advanced persistent threat detection products may be harmed, perhaps significantly, in the event that our new Intrusion Shield fails to perform as we expect it to. If Shield does not perform as we expect, if we experience product delivery delays, or if our customers do not perceive the benefits of purchasing and using Shield as part of their comprehensive cyber-security solution, our position as a leader in this technology space may be damaged and could affect customers, as well as potential customers, willingness to purchase our other products that function separately from our Intrusion Shield. Any reputational damage could result in a decrease in orders for all of our products, the loss of current customers, and a decrease in our overall revenues which could in turn have a material adverse effect on our results of operation.

We must expend time and resources addressing potential cyber-security risk, and any breach of our information security safeguards could have a material adverse effect on the Company.

The threat of cyber-attacks requires additional time and money to be expended in efforts to prevent any breaches of our information security protocols. However, we can provide no assurances that we can prevent any and all such attempts from being successful, which could result in expenses to address and remediate such breaches as well as potentially losing the confidence of our customers who depend upon our services to prevent and mitigate such attacks on their respective business. Should a material breach of our information security systems occur, it would likely have a material adverse impact on our business operations, our customer relations, and our current and future sales prospects, resulting in a significant loss of revenue.

We may not have sufficient cash to operate our business and may not be able to maintain future liquidity requirements. Additional debt and equity offerings to fund future operations may not be available and, if available, may significantly dilute the value of our currently outstanding common stock.

As of June 30, 2020, we had cash and cash equivalents of approximately $2,872,000, down from approximately $3,334,000 as of December 31, 2019. We had a net loss of $715,000 for the quarter ended June 30, 2020 compared to a net income of $1,758,000 for the quarter ended June 30, 2019. Based on projections of growth in revenue in the coming quarters, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures for the next twelve months. As of October 24, 2019, our funding available from the CEO Note terminated. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms are available on terms acceptable to the Company, if at all (the “Potential Replacement Funding Facility”).

We had a net loss of $0.7 million for the quarter ended June 30, 2020, and we have an accumulated deficit of $56.0 million as of June 30, 2020. To improve our financial performance, we must increase revenue levels of our existing product offerings and/or increase our revenue through the introduction and sale of our new Shield product.

For the quarter ended June 30, 2020, we had a net loss of $0.7 million and had an accumulated deficit of approximately $56.0 million as of June 30, 2020, compared to a net income of $1.8 million for the quarter ended June 30, 2019 and an accumulated deficit of approximately $54.8 million at December 31, 2019. We need to increase current revenue levels from the sales of our currently existing products or through the addition of sales of our new Shield product if we are to regain profitability. If we are unable to achieve these revenue levels, losses could continue for the near term and possibly longer, and we may not regain profitability or generate positive cash flow from operations in the future.

A large percentage of our revenues are received from U.S. government entities/resellers, and the loss of any one of these customers could reduce our revenues and materially harm our business and prospects.

A large percentage of our revenues result from sales to U.S. government entities/resellers. If we were to lose one or more of these key relationships, our revenues could decline and our business and prospects may be materially harmed. We expect that even if we are successful in developing relationships with non-governmental customers, our revenues will continue to be concentrated among government entities. For the quarter ended June 30, 2020, sales to U.S. government entities/resellers collectively accounted for 91.0% of our revenues, compared to 91.3% for the comparable period in 2019. The loss of any of these key relationships may send a negative message to other U.S. government entities or non-governmental customers concerning our product offering. We cannot assure you that U.S. government entities will be customers of ours in future periods or that we will be able to diversify our customer portfolio to adequately mitigate the risk of loss of any of these customers.

Almost all of our revenues are from one product line with a limited number of customers, and the decrease of revenue from sales of this product line could materially harm our business and prospects. Timeliness of orders from customers may cause volatility in growth.

Almost all of our revenues result from sales of one security product line. TraceCop revenues were $1.6 million for the quarter ended June 30, 2020, compared to $4.0 million for the second quarter 2019. Savant revenues increased to $106 thousand for the quarter ended June 30, 2020, compared to $29 thousand for the second quarter 2019. If sales of this key product line were to decrease, our revenues could decline and our business and prospects may be materially harmed. No individual commercial customer in the second quarter of 2020 and 2019 had over 10.0% of total revenue.

We are highly dependent on sales made through indirect channels, the loss of which would materially adversely affect our operations.

We derived 54.0% of revenue in the second quarter of 2020 through indirect channels of mainly government resellers, compared to 91.3% of our revenues in the quarter ended June 30, 2019. We must continue to expand our sales through these indirect channels in order to increase our revenues. We cannot assure you that our products will gain market acceptance in these indirect sales channels or that sales through these indirect sales channels will increase our revenues. Further, many of our competitors are also trying to sell their products through these indirect sales channels, which could result in lower prices and reduced profit margins for sales of our products.

You will experience substantial dilution upon the exercise of stock options currently outstanding.

On July 31, 2020, we had 13,792,030 shares of common stock outstanding. Upon the exercising of current options exercisable at or below the exercise price of $4.75, we would have approximately 14,546,533 shares of common stock outstanding, a 5.5% increase in the number of shares of our common stock outstanding.

Our management and larger stockholders exercise significant control over our company and have the ability to approve or take actions that may be adverse to your interests.

As of the date of this Quarterly Report, our executive officers and directors beneficially own approximately 28% of our voting power. In addition, other related non-affiliate parties control approximately 35% of voting power. As a result, these stockholders will be able to exercise significant control over all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, which could delay or prevent someone from acquiring or merging with us. These stockholders may use their influence to approve or take actions that may be adverse to the interests of holders of our Common Stock. Further, we contemplate the possible issuance of shares of our Common Stock or of securities exercisable or convertible into shares of our Common Stock in the future to our Chief Executive Officer, Chief Financial Officer and Senior Vice President. Any such issuance will increase the percentage of stock our Chief Executive Officer, Chief Financial Officer, Senior Vice President and our management group beneficially holds.

Item 6.

Exhibits

The following Exhibits are filed with this report form 10-Q:

31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Exchange Act.
32.1	Certification Pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

S I G N A T U R E S

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	INTRUSION INC.

Date: August 13, 2020	/s/ Jack B. Blount
	Jack B. Blount
	Director, President & Chief Executive Officer
	(Principal Executive Officer)


Date: August 13, 2020	/s/ Michael L. Paxton
	Michael L. Paxton
	Chairman, Vice President, Chief Financial Officer, Treasurer & Secretary
	(Principal Financial & Accounting Officer)

EX-31.1 2 ex_198283.htm EXHIBIT 31.1 ex_198283.htm

EXHIBIT 31.1

I, Jack B. Blount, Chief Executive Officer of Intrusion Inc., certify that:

(1)

I have reviewed this quarterly report on Form 10-Q of Intrusion Inc.;

(2)

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4)

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5)

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 13, 2020	/s/ Jack B. Blount
	Jack B. Blount
	Chief Executive Officer

EX-31.2 3 ex_198284.htm EXHIBIT 31.2 ex_198284.htm

EXHIBIT 31.2

I, Michael L. Paxton, Chief Financial Officer of Intrusion Inc., certify that:

(1)

I have reviewed this quarterly report on Form 10-Q of Intrusion Inc.;

(2)

(3)

(4)

(a)

(b)

(c)

(d)

(5)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 13, 2020	/s/ Michael L. Paxton
	Michael L. Paxton
	Chief Financial Officer

EX-32.1 4 ex_198285.htm EXHIBIT 32.1 ex_198285.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO RULE 13a-14(b) OF THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350, AS ENACTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Intrusion Inc. (the “Company”) on Form 10-Q, for the quarter ended June 30, 2020 (the “Report”) as filed with the Securities and Exchange Commission on the date hereof, each of the undersigned Officers of the Company does hereby certify, pursuant to 18 U.S.C. Section 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

August 13, 2020	/s/ Jack B. Blount
	Jack B. Blount
	Chief Executive Officer

August 13, 2020	/s/ Michael L. Paxton
	Michael L. Paxton
	Chief Financial Officer

The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Report or as a separate disclosure document.

EX-101.INS 5 intz-20200630.xml XBRL INSTANCE DOCUMENT false --12-31 Q2 2020 2020-06-30 10-Q 0000736012 13792030 Yes false Non-accelerated Filer Yes Intrusion Inc false true <div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: auto; margin-left: 36pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0pt" cellpadding="0pt"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Finance</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 46%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Period ending June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">363</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">39</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">402</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">363</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">368</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">375</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">375</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">384</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">384</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">159</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">159</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,644</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">44</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,688</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Less Interest*</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(183</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,461</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">43</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> </table></div> 1688000 159000 384000 375000 368000 402000 641000 11000 1 4 3 0 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font: inherit;">10.</div>   Right-of-use Asset and Leasing Liabilities</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Under the new lease accounting standard, we have determined that we have leases for right-of-use (ROU) assets. We have both finance right-of-use assets and operating right-of-use assets with a related lease liability. Our finance lease right-of-use assets consist of computer hardware and a copying machine. Our operating lease right-of-use assets include our rental agreements for our offices in Richardson and San Marcos, CA. Both types of lease liabilities are determined by the net present value of total payments and are amortized over the life of the lease. Both types of lease obligations are designed to terminate with the last scheduled payment. All of the finance lease right-of-use assets have a <div style="display: inline; font-style: italic; font: inherit;">three</div> year life and are in various stages of completion. The Richardson operating lease liability has a life of <div style="display: inline; font-style: italic; font: inherit;">four</div> years and <div style="display: inline; font-style: italic; font: inherit;">five</div> months as of <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020. </div>The San Marcos operating lease liability has a life of <div style="display: inline; font-style: italic; font: inherit;">nine</div> months as of <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020. </div>The adoption of the lease accounting standard resulted in the recognition of an operating ROU asset of <div style="display: inline; font-style: italic; font: inherit;">$1,553</div> thousand and a related lease liability of <div style="display: inline; font-style: italic; font: inherit;">$1,744</div> thousand during the <div style="display: inline; font-style: italic; font: inherit;">first</div> quarter of <div style="display: inline; font-style: italic; font: inherit;">2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Additional qualitative and quantitative disclosures regarding the Company's leasing arrangements are also required. The Company adopted ASC <div style="display: inline; font-style: italic; font: inherit;">842</div> prospectively and elected the package of transition practical expedients that does <div style="display: inline; font-style: italic; font: inherit;">not</div> require reassessment of: (<div style="display: inline; font-style: italic; font: inherit;">1</div>) whether any existing or expired contracts are or contain leases, (<div style="display: inline; font-style: italic; font: inherit;">2</div>) lease classification and (<div style="display: inline; font-style: italic; font: inherit;">3</div>) initial direct costs. In addition, the Company has elected other available practical expedients to <div style="display: inline; font-style: italic; font: inherit;">not</div> separate lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of <div style="display: inline; font-style: italic; font: inherit;">12</div> months or less.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As the implicit rate is <div style="display: inline; font-style: italic; font: inherit;">not</div> readily determinable for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates SVB's prime rate.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Supplemental cash flow information includes operating cash flows related to operating leases. For the <div style="display: inline; font-style: italic; font: inherit;">six</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> the Company had <div style="display: inline; font-style: italic; font: inherit;">$179</div> thousand and <div style="display: inline; font-style: italic; font: inherit;">$88</div> thousand, respectively, in operating cash flows related to operating leases.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Schedule of Items Appearing on the Statement</div><div style="display: inline; font-weight: bold;"> of Operations</div><div style="display: inline; font-weight: bold;">:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div> <table style="margin-right: 5%; margin-left: 18pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 20</div><div style="display: inline; font-weight: bold;">20</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 20</div><div style="display: inline; font-weight: bold;">20</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Operating expense:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 18pt;">Amortization expense – Finance ROU</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">11</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">16</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">21</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">32</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 18pt;">Lease expense – Operating ROU</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">82</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">83</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">165</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">162</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other expense:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 18pt;">Interest expense – Finance ROU</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Future minimum lease obligations consisted of the following at </div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;"> June 30</div></div><div style="display: inline; font-weight: bold;">, <div style="display: inline; font-style: italic; font: inherit;">20</div></div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">20</div></div><div style="display: inline; font-weight: bold;"> (in thousands):</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"> </div></div> <div> <table style="margin-right: auto; margin-left: 36pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0pt" cellpadding="0pt"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Operating</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Finance</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 46%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Period ending June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">ROU Leases</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">363</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">39</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">402</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">363</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">368</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">375</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">375</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">384</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">384</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">159</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">159</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,644</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">44</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1,688</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Less Interest*</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(183</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(1</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,461</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 15%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">43</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-4.5pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-4.5pt;">*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-4.5pt;"> </div></div> 124000 304000 6000 0.0728 P30D P45D

1152000

1080000

1067000

1566000

-43000

56946000

56759000

66000

62000

74000

14000

55000

10000

74000

14000

1942990

12132

1909289

6066

5938000

6835000

4327000

5052000

1611000

1783000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-Q and Item <div style="display: inline; font-style: italic; font: inherit;">10</div>-<div style="display: inline; font-style: italic; font: inherit;">01</div> of Regulation S-<div style="display: inline; font-style: italic; font: inherit;">X.</div> Accordingly, they do <div style="display: inline; font-style: italic; font: inherit;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019 </div>balance sheet was derived from audited financial statements, but does <div style="display: inline; font-style: italic; font: inherit;">not</div> include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented <div style="display: inline; font-style: italic; font: inherit;">not</div> misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div> and <div style="display: inline; font-style: italic; font: inherit;">six</div> month periods ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December </div><div style="display: inline; font-style: italic; font: inherit;">31,</div> <div style="display: inline; font-style: italic; font: inherit;">2019,</div> filed with the U.S. Securities and Exchange Commission (the “SEC”) on <div style="display: inline; font-style: italic; font: inherit;"> March 27, 2020.</div></div></div></div></div></div></div></div></div>

2872000

3334000

1652000

2872000

1477000

-462000

-175000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">8.</div>     Commitments and Contingencies</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do <div style="display: inline; font-style: italic; font: inherit;">not</div> believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide <div style="display: inline; font-style: italic; font: inherit;">no</div> assurances that legal claims that <div style="display: inline; font-style: italic; font: inherit;"> may </div>arise in the future will <div style="display: inline; font-style: italic; font: inherit;">not</div> have such a material impact on the Company.</div></div>

0.01

80000000

13802000

13552000

13792000

13542000

138000

136000

0.91

0.913

0.91

0.732

1067000

1566000

164000

516000

96000

63000

651000

1590000

1398000

2874000

0.01

107000

86000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font: inherit;">4.</div>     Accounting for Stock-Based Compensation</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">During the <div style="display: inline; font-style: italic; font: inherit;">three</div> month periods ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> the Company granted <div style="display: inline; font-style: italic; font: inherit;">323,000</div> and <div style="display: inline; font-style: italic; font: inherit;">24,000,</div> respectively, of stock options to employees or directors. The Company recognized <div style="display: inline; font-style: italic; font: inherit;">$55,000</div> and <div style="display: inline; font-style: italic; font: inherit;">$10,000,</div> respectively, of stock-based compensation expense for the <div style="display: inline; font-style: italic; font: inherit;">three</div> month periods ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019.</div> During the <div style="display: inline; font-style: italic; font: inherit;">six</div> month periods ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> the Company granted <div style="display: inline; font-style: italic; font: inherit;">323,000</div> and <div style="display: inline; font-style: italic; font: inherit;">24,000,</div> respectively, of stock options to employees and directors. The Company recognized <div style="display: inline; font-style: italic; font: inherit;">$74,000</div> and <div style="display: inline; font-style: italic; font: inherit;">$14,000,</div> respectively, of stock-based compensation expense for the <div style="display: inline; font-style: italic; font: inherit;">six</div> month periods ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">During the <div style="display: inline; font-style: italic; font: inherit;">three</div> month periods ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> <div style="display: inline; font-style: italic; font: inherit;">14,000</div> and <div style="display: inline; font-style: italic; font: inherit;">14,000</div> were exercised under the <div style="display: inline; font-style: italic; font: inherit;">2005</div> Plan, respectively. During the <div style="display: inline; font-style: italic; font: inherit;">six</div> month periods ended <div style="display: inline; font-style: italic; font: inherit;"> June 30, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019,</div> <div style="display: inline; font-style: italic; font: inherit;">186,600</div> and <div style="display: inline; font-style: italic; font: inherit;">280,500</div> were exercised under the <div style="display: inline; font-style: italic; font: inherit;">2005</div> Plan, respectively.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Valuation Assumptions</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;"> </div> <div> <table style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Three Months Ended</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 2020</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Three Months Ended </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 2019</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Six Months </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"> Ended</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 2020</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Six Months</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Ended</div><br /> <div style="display: inline; font-weight: bold;">June 30, 2019</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 44%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average grant date fair value</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.80</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3.61</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.80</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3.61</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average assumptions used:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected dividend yield</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.43</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.19</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.43</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.19</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected volatility</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">76.00</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">127.52</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">76.00</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">127.52</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected life (in years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.2</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.2</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Expected volatility is based on historical volatility and in part on implied volatility. The expected term considers the contractual term of the option as well as historical exercise and forfeiture behavior. The risk-free interest rate is based on the rates in effect on the grant date for U.S. Treasury instruments with maturities matching the relevant expected term of the award. Options granted to non-employees are valued using the fair market value on each measurement date of the option.</div></div>

19000

20000

66000

68000

13000

7000

19000

-0.05

0.13

-0.09

0.20

-0.05

0.11

-0.09

0.17

1000

2000

43000

38000

43000

5000

21000

44000

39000

5000

1000

21000

31000

41000

62000

11000

16000

21000

32000

326000

321000

582000

652000

1004000

2430000

2052000

4337000

-64000

-66000

-499000

738000

-352000

179000

234000

2000

9000

2000

44000

1000

7000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: 5%; margin-left: 18pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Six Months Ended</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 20</div><div style="display: inline; font-weight: bold;">20</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 20</div><div style="display: inline; font-weight: bold;">20</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 201</div><div style="display: inline; font-weight: bold;">9</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Operating expense:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 18pt;">Amortization expense – Finance ROU</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">11</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">16</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">21</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">32</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 18pt;">Lease expense – Operating ROU</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">82</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">83</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">165</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">162</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Other expense:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 18pt;">Interest expense – Finance ROU</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">1</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 10%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table></div>

P3Y

1644000

159000

384000

375000

363000

183000

P4Y244D

P270D

5938000

6835000

1949000

1943000

1520000

1336000

3700000

2700000

630000

285000

356000

345000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width: 2%; vertical-align: top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-style: italic; font: inherit;">1.</div></div> </td> <td style="vertical-align: top; width: 98%;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">Description of Business</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">We develop, market and support a family of entity identification, high speed data mining and cybersecurity solutions. Our products help detect, report and mitigate cybercrimes and advanced persistent threats.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our product families include:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">TraceCop for entity identification, cybercrime detection and disclosure, and;</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">Savant for high speed data mining, analytics, detection, reporting and mitigation of cybersecurity threats.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Our products in development include:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;">Intrusion Shield</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 18pt;">        We are in the process of developing a new product offering, Intrusion Shield, that is designed to be a next generation intrusion detection and protection solution.  After <div style="display: inline; font-style: italic; font: inherit;">20</div> years of providing research, analysis, and tools to the federal government and enterprise corporations, Intrusion possesses a comprehensive and proprietary database of Internet activity, including information about the activities of malicious online actors.  Intrusion's Shield product will combine that comprehensive database with artificial intelligence (AI) and real-time process flow technology to provide businesses and government agencies with a unique and affordable tool to detect, identify, and prevent cyber-crimes. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:12.3pt;margin-top:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:12.3pt;margin-top:0pt;text-align:left;text-indent:36pt;">Shield is a combination of plug-and-play hardware, software, global data, and AI services providing organizations with aggressive protection against unaddressed information security threats and the most robust defense possible against cybercrime. Unlike traditional industry approaches that rely heavily on human resources, which malicious actors have learned to bypass, Intrusion Shield uses our extensive database together with real-time AI technology to prevent illicit behavior.  Shield's proprietary architecture isolates and neutralizes malicious traffic and network flows that existing solutions cannot identify or even characterize. Most breaches today are caused by malware free compromises that trigger <div style="display: inline; font-style: italic; font: inherit;">no</div> alarms in a firewall or endpoint solution. The common denominator is network communications, and Shield monitors and analyses all network traffic and communications allowing it to identify and stop malware-free attacks. Shield's capabilities will continuously evolve based on real-time updates originating from our worldwide installations and growing TraceCop database identifying new dangers.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:12.3pt;margin-top:0pt;text-align:left;text-indent:18pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:12.3pt;margin-top:0pt;text-align:left;text-indent:36pt;">Shield does <div style="display: inline; font-style: italic; font: inherit;">not</div> seek to displace existing solutions, instead providing a new, and additional layer of cybersecurity for enterprises.  According to SBA <div style="display: inline; font-style: italic; font: inherit;">2019,</div> the U.S. enterprise market consists of <div style="display: inline; font-style: italic; font: inherit;">30.7</div> million businesses, of which <div style="display: inline; font-style: italic; font: inherit;">70%</div> are characterized as small and medium sized businesses.  While the company believes that many large enterprises will recognize the need this product addresses and will be incentivized to purchase Shield, the enterprise market has many decision makers for new security product purchases; therefore, the sale cycle <div style="display: inline; font-style: italic; font: inherit;"> may </div>be longer for this product than our current product offerings.  We have identified businesses with from <div style="display: inline; font-style: italic; font: inherit;">100</div> to <div style="display: inline; font-style: italic; font: inherit;">1,000</div> users as our initial target market, as we believe this market segment has the most pressing need for the enhanced protection that the Intrusion Shield will offer.  We intend to leverage existing and new channel partners, such as value added resellers and systems integrators, to market Shield to this target market.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 12.3pt 0pt 0pt; text-align: left; text-indent: 36pt;">Shield has experienced positive progress during Alpha testing and the Company has identified <div style="display: inline; font-style: italic; font: inherit;">twelve</div> companies for the Beta release anticipated to begin in <div style="display: inline; font-style: italic; font: inherit;"> September. </div>The configuration of hardware is a single Dell network appliance installed inline inside of the customer's firewall. The size of the network appliance will vary depending on the number of workstations and the size of the customer's internet connection be that <div style="display: inline; font-style: italic; font: inherit;">1Gb,</div> <div style="display: inline; font-style: italic; font: inherit;">10Gb</div> or <div style="display: inline; font-style: italic; font: inherit;">100</div> Gb.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Intrusion's products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We market and distribute our products through a direct sales force to:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;">●</td> <td style="vertical-align:top;">end-users, and</td> </tr> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;">●</td> <td style="vertical-align:top;">value-added resellers.</td> </tr> </table> <div style=" margin: 0pt;"> </div> <div style=" margin: 0pt; text-indent: 36pt;">Our end-user customers include:</div> <div style=" margin: 0pt;"> </div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">U.S. federal government entities,</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">state and local government entities,</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">large and diverse conglomerates,</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">manufacturing entities, and</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;"> </td> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;">other customers.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:72pt;margin-right:0pt;margin-top:0pt;text-align:justify;text-indent:-36pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 36pt;">We were organized in Texas in <div style="display: inline; font-style: italic; font: inherit;"> September 1983 </div>and reincorporated in Delaware in <div style="display: inline; font-style: italic; font: inherit;"> October 1995. </div>Our principal executive offices are located at <div style="display: inline; font-style: italic; font: inherit;">1101</div> East Arapaho Road, Suite <div style="display: inline; font-style: italic; font: inherit;">200,</div> Richardson, Texas <div style="display: inline; font-style: italic; font: inherit;">75081,</div> and our telephone number is (<div style="display: inline; font-style: italic; font: inherit;">972</div>) <div style="display: inline; font-style: italic; font: inherit;">234</div>-<div style="display: inline; font-style: italic; font: inherit;">6400.</div> Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. Trademarks of Intrusion include:</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">INTRUSION SHIELD</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">PROCESS FLOW TECHNOLOGY</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">INTRUSION SAVANT</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">BRINGING SCIENCE INTO DECISION MAKING</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">TRACECOP</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">INTRUSION PROTECT EVERYTHING. TRUST NOTHING</div> </td> </tr> </table> <table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:18pt;"> </td> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">●</div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;background-color:#FFFFFF;margin-bottom:0pt;font-size:10pt;">PROTECT EVERYTHING. TRUST NOTHING.</div> </td> </tr> </table></div>

626000

-2264000

-1026000

2257000

-1180000

2706000

-715000

1758000

-1180000

2706000

-748000

1723000

-1246000

2637000

630000

285000

-714000

1767000

-1185000

2750000

82000

83000

165000

162000

1744000

1461000

291000

284000

1170000

1315000

179000

88000

1553000

1223000

1348000

36000

38000

67000

644000

62000

168000

0.05

33000

35000

66000

69000

1012

1013

1054

1155

583

634

0.01

5000000

200000

420000

460000

266000

289000

200000

420000

460000

266000

289000

707000

661000

724000

379000

412000

388000

152000

629000

85000

226000

311000

335000

1815000

907000

296000

1660000

477000

-55957000

-54777000

1655000

4020000

3450000

7211000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: auto; margin-left: 45pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0pt" cellpadding="0pt"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Period ending June 30,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">PPP Loan</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2021</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">285</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2022</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">356</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2023</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2024</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">2025</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">—</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">641</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Less Interest*</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">(11</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">630</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Three Months Ended</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 2020</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Three Months Ended </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 2019</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Six Months </div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"> Ended</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">June 30, 2020</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For Six Months</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Ended</div><br /> <div style="display: inline; font-weight: bold;">June 30, 2019</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 44%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 11%;"> </td> <td style="width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average grant date fair value</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.80</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3.61</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.80</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">3.61</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt;">Weighted average assumptions used:</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 11%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected dividend yield</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Risk-free interest rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.43</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.19</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">0.43</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2.19</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected volatility</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">76.00</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">127.52</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">76.00</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">127.52</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">%</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 44%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0pt; margin-top: 0pt; margin-left: 9pt;">Expected life (in years)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.2</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">6.2</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 11%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">5.0</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table></div>

485000

46000

995000

458000

74000

14000

0.76

1.2752

0.76

1.2752

0.0043

0.0219

0.0043

0.0219

323000

24000

323000

24000

2.80

3.61

2.80

3.61

P6Y73D

P5Y

P6Y73D

P5Y

949000

886000

949000

13552000

13259000

13802000

13539000

-362000

1004249

63000

14000

186600

280500

187000

280000

1000

95000

1000

2000

84000

224000

2469000

3556000

1843000

1747000

1843000

136000

133000

138000

135000

56759000

56609000

56946000

56785000

-54777000

-59242000

-55957000

-56536000

-43000

1822000

10000

362000

13784000

15371000

13743000

15314000

13784000

13523000

13743000

13466000

Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations. xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0000736012 2019-01-01 2019-06-30 0000736012 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0000736012 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0000736012 us-gaap:PreferredStockMember 2019-01-01 2019-06-30 0000736012 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0000736012 2019-04-01 2019-06-30 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:CommercialCustomersMember 2019-04-01 2019-06-30 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:ThreeGovernmentCustomersMember 2019-04-01 2019-06-30 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:USGovernmentMember 2019-04-01 2019-06-30 0000736012 2020-01-01 2020-06-30 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2020-01-01 2020-06-30 0000736012 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-06-30 0000736012 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0000736012 us-gaap:PreferredStockMember 2020-01-01 2020-06-30 0000736012 us-gaap:RetainedEarningsMember 2020-01-01 2020-06-30 0000736012 2020-04-01 2020-06-30 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:CommercialCustomersMember 2020-04-01 2020-06-30 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:FourGovernmentCustomersMember 2020-04-01 2020-06-30 0000736012 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember intz:USGovernmentMember 2020-04-01 2020-06-30 0000736012 intz:Series1PreferredStockMember 2020-04-01 2020-06-30 0000736012 intz:Series2PreferredStockAndSeries3PreferredStockMember 2020-04-01 2020-06-30 0000736012 intz:Series2PreferredStockMember 2020-04-01 2020-06-30 0000736012 intz:Series3PreferredStockMember 2020-04-01 2020-06-30 0000736012 intz:PaycheckProtectionProgramCaresActMember 2020-04-30 2020-04-30 0000736012 us-gaap:SubsequentEventMember 2020-08-13 2020-08-13 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2018-02-08 0000736012 2018-12-31 0000736012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000736012 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000736012 us-gaap:CommonStockMember 2018-12-31 0000736012 us-gaap:PreferredStockMember 2018-12-31 0000736012 us-gaap:RetainedEarningsMember 2018-12-31 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2019-02-07 0000736012 2019-03-31 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2019-05-31 0000736012 2019-06-30 0000736012 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000736012 us-gaap:CommonStockMember 2019-06-30 0000736012 us-gaap:PreferredStockMember 2019-06-30 0000736012 us-gaap:RetainedEarningsMember 2019-06-30 0000736012 us-gaap:TreasuryStockMember 2019-06-30 0000736012 us-gaap:RevolvingCreditFacilityMember srt:ChiefExecutiveOfficerMember 2019-10-24 0000736012 2019-12-31 0000736012 intz:Series1PreferredStockMember 2019-12-31 0000736012 intz:Series2PreferredStockMember 2019-12-31 0000736012 intz:Series3PreferredStockMember 2019-12-31 0000736012 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000736012 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000736012 us-gaap:CommonStockMember 2019-12-31 0000736012 us-gaap:PreferredStockMember 2019-12-31 0000736012 us-gaap:RetainedEarningsMember 2019-12-31 0000736012 2020-06-30 0000736012 intz:PaycheckProtectionProgramCaresActMember 2020-06-30 0000736012 intz:RichardsonPropertyMember 2020-06-30 0000736012 intz:TheSanMarcosPropertyMember 2020-06-30 0000736012 intz:Series1PreferredStockMember 2020-06-30 0000736012 intz:Series2PreferredStockMember 2020-06-30 0000736012 intz:Series3PreferredStockMember 2020-06-30 0000736012 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000736012 us-gaap:CommonStockMember 2020-06-30 0000736012 us-gaap:PreferredStockMember 2020-06-30 0000736012 us-gaap:RetainedEarningsMember 2020-06-30 0000736012 us-gaap:TreasuryStockMember 2020-06-30 0000736012 2020-07-31 0000736012 us-gaap:SubsequentEventMember 2020-08-13

EX-101.SCH 6 intz-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Unaudited Condensed Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Unaudited Condensed Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Unaudited Condensed Consolidated Statements of Changes In Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Description of Business link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Loan Payable to Officer link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Accounting for Stock-based Compensation link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Revenue Recognition link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Concentrations link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Dividends Payable link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - PPP Loan link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Coronavirus Outbreak in the United States link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 4 - Accounting for Stock-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 11 - PPP Loan (Tables) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 3 - Loan Payable to Officer (Details Textual) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 4 - Accounting for Stock-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 4 - Accounting for Stock-based Compensation - Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 5 - Revenue Recognition (Details Textual) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 7 - Concentrations (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 9 - Dividends Payable (Details Textual) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities (Details Textual) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities - Schedule of Items Appearing on the Statement of Operations (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities - Future Minimum Lease Obligations (Details) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 11 - PPP Loan (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 11 - PPP Loan - Future Minimum Loan Obligations (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 13 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 7 intz-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 intz-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 intz-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Expected dividend yield Fair Value of Financial Instruments, Policy [Policy Text Block] Note To Financial Statement Details Textual Significant Accounting Policies Note 4 - Accounting for Stock-based Compensation Note 10 - Right-of-use Asset and Leasing Liabilities Risk-free interest rate Operating ROU Leases, 2024 Note 11 - PPP Loan Operating ROU Leases, 2025 Note 4 - Accounting for Stock-based Compensation - Valuation Assumptions (Details) Operating ROU Leases, Thereafter Note 10 - Right-of-use Asset and Leasing Liabilities - Schedule of Items Appearing on the Statement of Operations (Details) Noncurrent Liabilities: Note 10 - Right-of-use Asset and Leasing Liabilities - Future Minimum Lease Obligations (Details) Note 11 - PPP Loan - Future Minimum Loan Obligations (Details) Operating ROU Leases, 2021 Operating ROU Leases, 2022 Notes To Financial Statements Operating ROU Leases, 2023 Notes To Financial Statements [Abstract] Other assets Stock-based compensation Expected volatility us-gaap_LiabilitiesCurrent Total current liabilities Schedule of Maturities of Long-term Debt [Table Text Block] Weighted average assumptions used: Expected life (in years) (Year) Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Operating expenses: Series 2 Preferred Stock [Member] Represents series 2 preferred stock. Series 1 Preferred Stock [Member] Represents series 1 preferred stock. us-gaap_LesseeOperatingLeaseTermOfContract Lessee, Operating Lease, Term of Contract (Year) Series 3 Preferred Stock [Member] Represents series 3 preferred stock. Conversion of preferred stock to common Conversion of preferred stock to common Depreciation and amortization us-gaap_ConversionOfStockSharesConverted1 Conversion of preferred stock to common (in shares) us-gaap_AssetsCurrent Total current assets Noncurrent Assets: PPP loan payable, current portion Stockholders' Equity Note Disclosure [Text Block] intz_LongtermDebtExpectedInterest Less Interest* Amount of interest expected to be recognized over the life of the loan. intz_LongtermDebtBeforeExpectedInterest Long-term Debt, Before Expected Interest Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, but before expected interest. Paycheck Protection Program CARES Act [Member] Represents loan designed to provide funds for small businesses to keep their employees on the payroll. Weighted average grant date fair value (in dollars per share) us-gaap_LesseeFinanceLeaseTermOfContract1 Lessee, Finance Lease, Term of Contract (Year) Common stock held in treasury, at cost, shares (in shares) intz_PercentageDilutionFromConversionOfPreferredStock Percentage Dilution from Conversion of Preferred Stock Percentage dilution from each newly issued share of common stock from voluntary conversion of preferred stock. Common stock, $0.01 par value: Authorized shares — 80,000 Issued shares — 13,802 in 2020 and 13,552 in 2019 Outstanding shares — 13,792 in 2020 and 13,542 in 2019 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Common stock, shares authorized (in shares) Accounts payable and accrued expenses Common stock, shares issued (in shares) Deferred revenue Contract with Customer, Liability, Current Common stock, par value (in dollars per share) us-gaap_OperatingLeasePayments Operating Lease, Payments Dividends payable Revolving Credit Facility [Member] Preferred stock, liquidation preference (in dollars per share) Credit Facility [Axis] Credit Facility [Domain] us-gaap_ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total Preferred stock Preferred stock, shares issued (in shares) us-gaap_PolicyTextBlockAbstract Accounting Policies Prepaid expenses Preferred stock, shares authorized (in shares) Preferred stock, par value (in dollars per share) Revenue us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchases of property and equipment SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES: Customer [Axis] Customer [Domain] Weighted average common shares outstanding: Current Liabilities: intz_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. intz_NumberOfAreasInWhichOperationsAreConcentrated Number of Areas in Which Operations are Concentrated Represents the number of areas in which operations of the entity are concentrated. us-gaap_Assets TOTAL ASSETS U.S. Government [Member] Represents the U.S. Government. Deferred revenue us-gaap_IncreaseDecreaseInDeferredRevenue Commercial Customers [Member] Represents commercial customers. us-gaap_PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage Operating Activities: Lease expense – Operating ROU us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Net income (loss) attributable to common stockholders Statement [Line Items] Accounts receivable Additional paid-in capital Share-based Payment Arrangement [Text Block] AOCI Attributable to Parent [Member] Stockholders’ equity: Series 2 Preferred Stock and Series 3 Preferred Stock [Member] Series 2 preferred stock and Series 3 preferred stock. Noncash lease costs Amount of amortization expense for right-of-use asset from operating lease. us-gaap_PreferredStockDividendsIncomeStatementImpact Preferred stock dividends accrued Chief Executive Officer [Member] Current Assets: Basis of Presentation and Significant Accounting Policies [Text Block] Net income (loss) Net income (loss) us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Four Government Customers [Member] Represents four government customers. us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net decrease in cash and cash equivalents Interest income us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by (used in) financing activities Commitments and contingencies us-gaap_OperatingIncomeLoss Operating income (loss) us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash provided by (used in) operating activities us-gaap_GrossProfit Gross profit Cost of revenue Three Government Customers [Member] Represents three government customers. Commitments and Contingencies Disclosure [Text Block] Property and equipment, net Contingencies Disclosure [Text Block] us-gaap_InterestPayableCurrentAndNoncurrent Interest Payable us-gaap_PaymentsOfDividends Payments of dividends Investing Activities: Retained Earnings [Member] Earnings Per Share [Text Block] Proceeds from stock options exercised Treasury Stock [Member] Accounts payable and accrued expenses us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Additional Paid-in Capital [Member] Common Stock [Member] Related Party Transactions Disclosure [Text Block] Preferred Stock [Member] Equity Components [Axis] Equity Component [Domain] Long-term Debt, Total us-gaap_NotesPayable Notes Payable, Total General and administrative us-gaap_LineOfCredit Long-term Line of Credit, Total Cash and cash equivalents intz_PeriodOfPaymentTermsOfferedToCustomersDistributionsAndResellersDomestically Period of Payment Terms Offered to Customers Distributions and Resellers Domestically (Day) Represents the period of payment terms offered to domestic customers, distributors and resellers. intz_PeriodOfPaymentTermsOfferedToCustomersDistributorsAndResllersInternationally Period of Payment Terms Offered to Customers Distributors and Resllers Internationally (Day) Represents the period of payment terms offered to international customers, distributors and resellers. Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block] Tabular disclosure of undiscounted cash flows of lessee's operating lease liability and finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability and finance lease liability recognized in statement of financial position. us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense Revenue from Contract with Customer [Text Block] us-gaap_RepaymentsOfRelatedPartyDebt Payments on loan from officer intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearThree 2023 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearTwo 2022 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueNextRollingTwelveMonths 2021 Amount of lessee's undiscounted obligation for lease payments for operating lease and finance lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. Amendment Flag intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueAfterRollingYearFive Thereafter Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date. Accounting Policies [Abstract] intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFive 2025 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDueInRollingYearFour 2024 Amount of lessee's undiscounted obligation for lease payments for operating and finance lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date. Basis of Accounting, Policy [Policy Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Concentration Risk Disclosure [Text Block] Entity Interactive Data Current intz_LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue Lessee, Operating and Finance Lease, Liability, Payments, Due Amount of lessee's undiscounted obligation for lease payments for operating and finance lease. 2024 2025 Thereafter Balance, beginning of quarter and end of quarter (in shares) Balance, beginning of quarter (in shares) Balance, end of quarter (in shares) Common stock, shares outstanding (in shares) 2021 Preferred stock, shares outstanding (in shares) 2022 2023 Current Fiscal Year End Date us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate Proceeds from PPP loan payable Proceeds from Issuance of Long-term Debt, Total us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other assets Operating and Finance Leases Of Lessee Disclosure [Text Block] The entire disclosure for operating and finance leases of lessee. Includes, but is not limited to, description of operating and finance lease and maturity analysis of operating and finance lease liability. Document Fiscal Period Focus Document Fiscal Year Focus Lease, Cost [Table Text Block] Document Period End Date Penalties on dividends Amount of penalties and waived penalties on dividends during the period. Entity Emerging Growth Company Document Type Entity Small Business Entity Shell Company Document Information [Line Items] us-gaap_DividendsPreferredStock Dividends, Preferred Stock, Total Document Information [Table] Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] Name of Property [Axis] Name of Property [Domain] us-gaap_AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Preferred stock dividends declared, net of waived penalties by shareholders us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) Diluted (in shares) us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Stock-based compensation Entity Central Index Key Entity Registrant Name EX-101.PRE 10 intz-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	6 Months Ended
Document And Entity Information - shares	Jun. 30, 2020	Jul. 31, 2020
Document Information [Line Items]
Entity Registrant Name	Intrusion Inc
Entity Central Index Key	0000736012
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		13,792,030
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Jun. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Amendment Flag	false

XML 12 R2.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 2,872,000	$ 3,334,000
Accounts receivable	1,067,000	1,566,000
Prepaid expenses	388,000	152,000
Total current assets	4,327,000	5,052,000
Noncurrent Assets:
Property and equipment, net	311,000	335,000
Finance leases, right-of-use assets, net	41,000	62,000
Operating leases, right-of-use asset, net	1,223,000	1,348,000
Other assets	36,000	38,000
Total noncurrent assets	1,611,000	1,783,000
TOTAL ASSETS	5,938,000	6,835,000
Current Liabilities:
Accounts payable and accrued expenses	1,152,000	1,080,000
Dividends payable	19,000	20,000
Finance leases liability, current portion	38,000	43,000
Operating leases liability, current portion	291,000	284,000
PPP loan payable, current portion	285,000
Deferred revenue	164,000	516,000
Total current liabilities	1,949,000	1,943,000
Noncurrent Liabilities:
Finance leases liability, noncurrent portion	5,000	21,000
Operating leases liability, noncurrent portion	1,170,000	1,315,000
PPP loan payable, noncurrent portion	345,000
Total noncurrent liabilities	1,520,000	1,336,000
Commitments and contingencies
Stockholders’ equity:
Common stock, $0.01 par value: Authorized shares — 80,000 Issued shares — 13,802 in 2020 and 13,552 in 2019 Outstanding shares — 13,792 in 2020 and 13,542 in 2019	138,000	136,000
Common stock held in treasury, at cost – 10 shares	(362,000)	(362,000)
Additional paid-in capital	56,946,000	56,759,000
Accumulated deficit	(55,957,000)	(54,777,000)
Accumulated other comprehensive loss	(43,000)	(43,000)
Total stockholders’ equity	2,469,000	3,556,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	5,938,000	6,835,000
Series 1 Preferred Stock [Member]
Stockholders’ equity:
Preferred stock	707,000	707,000
Series 2 Preferred Stock [Member]
Stockholders’ equity:
Preferred stock	661,000	724,000
Series 3 Preferred Stock [Member]
Stockholders’ equity:
Preferred stock	$ 379,000	$ 412,000

XML 13 R3.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares shares in Thousands	Jun. 30, 2020	Dec. 31, 2019
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	5,000	5,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	80,000	80,000
Common stock, shares issued (in shares)	13,802	13,552
Common stock, shares outstanding (in shares)	13,792	13,542
Common stock held in treasury, at cost, shares (in shares)	10	10
Series 1 Preferred Stock [Member]
Preferred stock, shares issued (in shares)	200	200
Preferred stock, shares outstanding (in shares)	200	200
Preferred stock, liquidation preference (in dollars per share)	$ 1,012	$ 1,013
Series 2 Preferred Stock [Member]
Preferred stock, shares issued (in shares)	420	460
Preferred stock, shares outstanding (in shares)	420	460
Preferred stock, liquidation preference (in dollars per share)	$ 1,054	$ 1,155
Series 3 Preferred Stock [Member]
Preferred stock, shares issued (in shares)	266	289
Preferred stock, shares outstanding (in shares)	266	289
Preferred stock, liquidation preference (in dollars per share)	$ 583	$ 634

XML 14 R4.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue	$ 1,655	$ 4,020	$ 3,450	$ 7,211
Cost of revenue	651	1,590	1,398	2,874
Gross profit	1,004	2,430	2,052	4,337
Operating expenses:
Sales and marketing	485	46	995	458
Research and development	907	296	1,660	477
General and administrative	326	321	582	652
Operating income (loss)	(714)	1,767	(1,185)	2,750
Interest income	1		7
Interest expense	(2)	(9)	(2)	(44)
Net income (loss)	(715)	1,758	(1,180)	2,706
Preferred stock dividends accrued	(33)	(35)	(66)	(69)
Net income (loss) attributable to common stockholders	$ (748)	$ 1,723	$ (1,246)	$ 2,637
Net income (loss) per share attributable to common stockholders:
Basic (in dollars per share)	$ (0.05)	$ 0.13	$ (0.09)	$ 0.20
Diluted (in dollars per share)	$ (0.05)	$ 0.11	$ (0.09)	$ 0.17
Weighted average common shares outstanding:
Basic (in shares)	13,784	13,523	13,743	13,466
Diluted (in shares)	13,784	15,371	13,743	15,314

XML 15 R5.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Consolidated Statements of Changes In Stockholders' Equity - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance, beginning of quarter and end of quarter (in shares)	949,000	13,259,000
Balance, beginning of quarter (in shares) at Dec. 31, 2018	949,000	13,259,000
Conversion of preferred stock to common (in shares)
Balance, end of quarter (in shares) at Jun. 30, 2019	949,000	13,539,000	(362,000)
Balance, beginning of quarter at Dec. 31, 2018	$ 1,843	$ 133		$ 56,609	$ (59,242)	$ (43)
Conversion of preferred stock to common
Balance, end of quarter at Jun. 30, 2019	$ 1,843	$ 135		56,785	(56,536)		$ 1,822
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)
Exercise of stock options (in shares)		280,000					280,500
Conversion of preferred stock to common
Exercise of stock options		$ 2		224
Balance, beginning of quarter and end of quarter (in shares)	949,000	13,539,000	(362,000)
Stock-based compensation				14
Preferred stock dividends declared, net of waived penalties by shareholders				(62)
Net income (loss)					2,706		$ 2,706
Balance, beginning of quarter and end of quarter (in shares)	949,000	13,539,000	(362,000)
Balance, beginning of quarter and end of quarter (in shares)	949,000	13,552,000
Balance, beginning of quarter (in shares) at Dec. 31, 2019	949,000	13,552,000
Conversion of preferred stock to common (in shares)	(63,000)
Balance, end of quarter (in shares) at Jun. 30, 2020	886,000	13,802,000	(362,000)
Balance, beginning of quarter at Dec. 31, 2019	$ 1,843	$ 136		56,759	(54,777)	$ (43)	3,556
Conversion of preferred stock to common	(96)						(96)
Balance, end of quarter at Jun. 30, 2020	$ 1,747	$ 138		56,946	(55,957)		$ 2,469
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)		63,000
Exercise of stock options (in shares)		187,000					186,600
Conversion of preferred stock to common		$ 1		95
Exercise of stock options		$ 1		84
Balance, beginning of quarter and end of quarter (in shares)	886,000	13,802,000	(362,000)
Stock-based compensation				74
Preferred stock dividends declared, net of waived penalties by shareholders				$ (66)
Net income (loss)					$ (1,180)		$ (1,180)
Balance, beginning of quarter and end of quarter (in shares)	886,000	13,802,000	(362,000)

XML 16 R6.htm IDEA: XBRL DOCUMENT

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Operating Activities:
Net income (loss)	$ (1,180)	$ 2,706
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	107	86
Stock-based compensation	74	14
Penalties on dividends		6
Noncash lease costs	124	304
Changes in operating assets and liabilities:
Accounts receivable	499	(738)
Prepaid expenses and other assets	(234)	(234)
Accounts payable and accrued expenses	(64)	(66)
Deferred revenue	(352)	179
Net cash provided by (used in) operating activities	(1,026)	2,257
Investing Activities:
Purchases of property and equipment	(62)	(168)
Financing Activities:
Proceeds from PPP loan payable	629
Payments on loan from officer		(1,815)
Proceeds from stock options exercised	85	226
Payments of dividends	(67)	(644)
Reduction of finance lease liability	(21)	(31)
Net cash provided by (used in) financing activities	626	(2,264)
Net decrease in cash and cash equivalents	(462)	(175)
Cash and cash equivalents at beginning of period	3,334	1,652
Cash and cash equivalents at end of period	2,872	1,477
SUPPLEMENTAL DISCLOSURE OF NON CASH FINANCING ACTIVITIES:
Preferred stock dividends accrued	66	68
Conversion of preferred stock to common	$ 96

XML 17 R7.htm IDEA: XBRL DOCUMENT

Note 1 - Description of Business

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

Nature of Operations [Text Block]

1.	Description of Business

Our product families include:

●

TraceCop for entity identification, cybercrime detection and disclosure, and;

●

Savant for high speed data mining, analytics, detection, reporting and mitigation of cybersecurity threats.

Our products in development include:

●

Intrusion Shield

We are in the process of developing a new product offering, Intrusion Shield, that is designed to be a next generation intrusion detection and protection solution. After

years of providing research, analysis, and tools to the federal government and enterprise corporations, Intrusion possesses a comprehensive and proprietary database of Internet activity, including information about the activities of malicious online actors. Intrusion's Shield product will combine that comprehensive database with artificial intelligence (AI) and real-time process flow technology to provide businesses and government agencies with a unique and affordable tool to detect, identify, and prevent cyber-crimes.

alarms in a firewall or endpoint solution. The common denominator is network communications, and Shield monitors and analyses all network traffic and communications allowing it to identify and stop malware-free attacks. Shield's capabilities will continuously evolve based on real-time updates originating from our worldwide installations and growing TraceCop database identifying new dangers.

Shield does

not

seek to displace existing solutions, instead providing a new, and additional layer of cybersecurity for enterprises. According to SBA

2019,

the U.S. enterprise market consists of

30.7

million businesses, of which

70%

are characterized as small and medium sized businesses. While the company believes that many large enterprises will recognize the need this product addresses and will be incentivized to purchase Shield, the enterprise market has many decision makers for new security product purchases; therefore, the sale cycle

may

be longer for this product than our current product offerings. We have identified businesses with from

100

1,000

users as our initial target market, as we believe this market segment has the most pressing need for the enhanced protection that the Intrusion Shield will offer. We intend to leverage existing and new channel partners, such as value added resellers and systems integrators, to market Shield to this target market.

Shield has experienced positive progress during Alpha testing and the Company has identified

twelve

companies for the Beta release anticipated to begin in

September.

The configuration of hardware is a single Dell network appliance installed inline inside of the customer's firewall. The size of the network appliance will vary depending on the number of workstations and the size of the customer's internet connection be that

1Gb,

10Gb

100

Gb.

Intrusion's products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.

We market and distribute our products through a direct sales force to:

	●	end-users, and
	●	value-added resellers.

Our end-user customers include:

●

U.S. federal government entities,

●

state and local government entities,

●

large and diverse conglomerates,

●

manufacturing entities, and

●

other customers.

We were organized in Texas in

September 1983

and reincorporated in Delaware in

October 1995.

Our principal executive offices are located at

1101

East Arapaho Road, Suite

200,

Richardson, Texas

75081,

and our telephone number is (

972

)

234

6400.

Our website URL is www.intrusion.com. References to the “Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. Trademarks of Intrusion include:

●

INTRUSION SHIELD

●

PROCESS FLOW TECHNOLOGY

●

INTRUSION SAVANT

●

BRINGING SCIENCE INTO DECISION MAKING

●

TRACECOP

●

INTRUSION PROTECT EVERYTHING. TRUST NOTHING

●

PROTECT EVERYTHING. TRUST NOTHING.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Note 2 - Basis of Presentation	6 Months Ended
Note 2 - Basis of Presentation	Jun. 30, 2020
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	2. Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10 -Q and Item 10 - 01 of Regulation S- X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2019 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three and six month periods ended June 30, 2020 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10 -K for the year ended December 31, 2019, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 27, 2020. The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do not bear market rates of interest. Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes. On January 1, 2019 we adopted ASU No. 2016 - 02, Leases (topic 842 ) . At the date of adoption there was no impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU No. 2016 - 02 did not have a material effect on the Company's results of operations or cash flows for the three and six month periods ended June 30, 2020 and 2019.

XML 19 R9.htm IDEA: XBRL DOCUMENT

Note 3 - Loan Payable to Officer	6 Months Ended
Note 3 - Loan Payable to Officer	Jun. 30, 2020
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	3. Loan Payable to Officer On February 8, 2018, the Company entered into an unsecured revolving promissory note to borrow up to $3,700,000 from G. Ward Paxton. Under the terms of the CEO Note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $3,700,000 at any given time through March 2020. On February 7, 2019, the Company amended the unsecured revolving promissory note to borrow up to $2,700,000 from G. Ward Paxton, the Company's former Chief Executive Officer. Amounts borrowed under the CEO Note accrued interest at a floating rate per annum equal to Silicon Valley Bank's (“SVB”) prime rate plus 1%. Under the terms of the note, the Company had the ability to borrow, repay and reborrow on the loan as needed up to an outstanding principal balance due of $2,700,000 at any given time through March 2021. We reduced our borrowing under this note to zero as of May 2019. As of October 24, 2019, G. Ward Paxton passed away, terminating the CEO Note with the result that future borrowings thereunder will no longer be available to the Company. Our management will be assessing whether to replace this borrowing capacity and assessing what terms may be available to the Company, including whether any such terms are acceptable to the Company, if at all.

XML 20 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Accounting for Stock-based Compensation

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]

Accounting for Stock-Based Compensation

During the

three

month periods ended

June 30, 2020

and

2019,

the Company granted

323,000

and

24,000,

respectively, of stock options to employees or directors. The Company recognized

$55,000

and

$10,000,

respectively, of stock-based compensation expense for the

three

month periods ended

June 30, 2020

and

2019.

During the

six

month periods ended

June 30, 2020

and

2019,

the Company granted

323,000

and

24,000,

respectively, of stock options to employees and directors. The Company recognized

$74,000

and

$14,000,

respectively, of stock-based compensation expense for the

six

month periods ended

June 30, 2020

and

2019.

During the

three

month periods ended

June 30, 2020

and

2019,

14,000

and

14,000

were exercised under the

2005

Plan, respectively. During the

six

month periods ended

June 30, 2020

and

2019,

186,600

and

280,500

were exercised under the

2005

Plan, respectively.

Valuation Assumptions

The fair values of employee and director option awards were estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

	For Three Months Ended June 30, 2020			For Three Months Ended June 30, 2019			For Six Months Ended June 30, 2020			For Six Months Ended June 30, 2019

Weighted average grant date fair value	$	2.80		$	3.61		$	2.80		$	3.61
Weighted average assumptions used:
Expected dividend yield		0.0	%		0.0	%		0.0	%		0.0	%
Risk-free interest rate		0.43	%		2.19	%		0.43	%		2.19	%
Expected volatility		76.00	%		127.52	%		76.00	%		127.52	%
Expected life (in years)		6.2			5.0			6.2			5.0

XML 21 R11.htm IDEA: XBRL DOCUMENT

Note 5 - Revenue Recognition

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

Revenue Recognition

not

currently offer software on a subscription basis. Warranty costs and sales returns have

not

been material.

We recognize sales of our data sets in accordance with FASB ASC Topic

606

whereby revenue from contracts with

customers is

not

recognized until all

five

of the following have been met:

identify the contract with a customer;

ii)

identify the performance obligations in the contract;

iii)

determine the transaction price;

	iv)	allocate the transaction price to the separate performance obligations; and
	v)	recognize revenue upon satisfaction of a performance obligation.

Data updates are typically done monthly and revenue will be matched accordingly. Product sales

may

include maintenance and customer support allocated revenue in an arrangement using estimated selling prices of the delivered goods and services based on a selling price hierarchy using the relative selling price method. All of our product offering and service offering market values are readily determined based on current and prior stand-alone sales. We

may

defer and recognize maintenance, updates and support revenue over the term of the contract period, which is generally

one

year.

not

been material. These revenues are included in net customer support and maintenance revenues in the statement of operations.

Our normal payment terms offered to customers, distributors and resellers are net

days domestically and net

days internationally. We do

not

offer payment terms that extend beyond

one

year and rarely do we extend payment terms beyond our normal terms. If certain customers do

not

meet our credit standards, we do require payment in advance to limit our credit exposure.

Contract assets represent contract billings for sales per contracts with customers and are classified as current. Our contract assets include our accounts receivables. At

June 30, 2020,

the Company had contract assets balance of

$1,067,000.

December 31, 2019,

the Company had contract assets balance of

$1,566,000.

June 30, 2020,

the Company had contract liabilities balance of

$164,000.

December 31, 2019,

the Company had contract liabilities balance of

$516,000.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI http://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045

+ Details

XML 22 R12.htm IDEA: XBRL DOCUMENT

Note 6 - Net Income (Loss) Per Share	6 Months Ended
Note 6 - Net Income (Loss) Per Share	Jun. 30, 2020
Notes to Financial Statements
Earnings Per Share [Text Block]	6. Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income attributable to common stockholders for the period by the weighted average number of common shares outstanding for the period. Diluted net income (loss) per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of common shares and dilutive common stock equivalents outstanding for the period. Our common stock equivalents include all common stock issuable upon conversion of preferred stock and the exercise of outstanding options. The aggregate number of common stock equivalents excluded from the diluted income (loss) per share calculation for the three month periods ended June 30, 2020 and 2019 are 1,942,990 and 12,132, respectively. The aggregate number of common stock equivalents excluded from the diluted income (loss) per share calculation for the six month periods ended June 30, 2020 and 2019 are 1,909,289 and 6,066, respectively. Since the Company is in a net loss position for the three and six month periods ending June 30, 2020, basic and dilutive net loss per share are the same.

XML 23 R13.htm IDEA: XBRL DOCUMENT

Note 7 - Concentrations	6 Months Ended
Note 7 - Concentrations	Jun. 30, 2020
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	7. Concentrations Our operations are concentrated in one area—security software/entity identification. Sales to the U.S. Government through direct and indirect channels totaled 91.0% of total revenues for the second quarter of 2020 compared to 91.3% of total revenues for the second quarter of 2019. During the second quarter of 2020, approximately 91.0% of total revenues were attributable to four government customers compared to approximately 73.2% of total revenues attributable to three government customers in the second quarter of 2019. In the second quarter of 2020, no individual commercial customer had revenues over 10.0% of total revenue compared to no individual commercial customer for the same period in 2019. Our similar product and service offerings are not viewed as individual segments, as our management analyzes the business as a whole and expenses are not allocated to each product offering.

XML 24 R14.htm IDEA: XBRL DOCUMENT

Note 8 - Commitments and Contingencies	6 Months Ended
Note 8 - Commitments and Contingencies	Jun. 30, 2020
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	8. Commitments and Contingencies We are subject from time to time to various legal proceedings and claims that arise during the ordinary course of our business. We do not believe that the outcome of those "routine" legal matters should have a material adverse effect on our consolidated financial position, operating results or cash flows; however, we can provide no assurances that legal claims that may arise in the future will not have such a material impact on the Company.

XML 25 R15.htm IDEA: XBRL DOCUMENT

Note 9 - Dividends Payable	6 Months Ended
Note 9 - Dividends Payable	Jun. 30, 2020
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	9. Dividends Payable During the quarter ended June 30, 2020, we accrued $13,000 in dividends payable to the holders of our 5% Preferred Stock, $13,000 in dividends payable to the holders of our Series 2 5% Preferred Stock and $7,000 in dividends payable to the holders of our Series 3 5% Preferred Stock. As of June 30, 2020, we had $19,000 in accrued and unpaid dividends, all of which have been paid as of the date of this Quarterly Report.

XML 26 R16.htm IDEA: XBRL DOCUMENT

Note 10 - Right-of-use Asset and Leasing Liabilities

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

Operating and Finance Leases Of Lessee Disclosure [Text Block]

10.

Right-of-use Asset and Leasing Liabilities

three

year life and are in various stages of completion. The Richardson operating lease liability has a life of

four

years and

five

months as of

June 30, 2020.

The San Marcos operating lease liability has a life of

nine

months as of

June 30, 2020.

The adoption of the lease accounting standard resulted in the recognition of an operating ROU asset of

$1,553

thousand and a related lease liability of

$1,744

thousand during the

first

quarter of

2019.

Additional qualitative and quantitative disclosures regarding the Company's leasing arrangements are also required. The Company adopted ASC

842

prospectively and elected the package of transition practical expedients that does

not

require reassessment of: (

) whether any existing or expired contracts are or contain leases, (

) lease classification and (

) initial direct costs. In addition, the Company has elected other available practical expedients to

not

separate lease and non-lease components, which consist principally of common area maintenance charges, for all classes of underlying assets and to exclude leases with an initial term of

months or less.

As the implicit rate is

not

readily determinable for the Company's lease agreement, the Company uses an estimated incremental borrowing rate to determine the initial present value of lease payments. This discount rate for the lease approximates SVB's prime rate.

Supplemental cash flow information includes operating cash flows related to operating leases. For the

six

months ended

June 30, 2020

and

2019,

the Company had

$179

thousand and

$88

thousand, respectively, in operating cash flows related to operating leases.

Schedule of Items Appearing on the Statement

of Operations

	Three Months Ended				Six Months Ended
	June 30, 20 20		June 30, 201 9		June 30, 20 20		June 30, 201 9
Operating expense:
Amortization expense – Finance ROU	$	11	$	16	$	21	$	32
Lease expense – Operating ROU		82		83		165		162
Other expense:
Interest expense – Finance ROU	$	—	$	1	$	1	$	2

Future minimum lease obligations consisted of the following at

June 30

(in thousands):

	Operating			Finance
Period ending June 30,	ROU Leases			ROU Leases			Total
2021	$	363		$	39		$	402
2022		363			5			368
2023		375			—			375
2024		384			—			384
2025		159			—			159
Thereafter		—			—			—
	$	1,644		$	44		$	1,688
Less Interest*		(183	)		(1	)
	$	1,461		$	43

*Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.

XML 27 R17.htm IDEA: XBRL DOCUMENT

Note 11 - PPP Loan

6 Months Ended

Jun. 30, 2020

Notes to Financial Statements

Debt Disclosure [Text Block]

11.

PPP Loan

March 27, 2020,

the U.S. federal government enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), which includes provision for a Paycheck Protection Program (“PPP”) administered by the U.S. Small Business Administration (“SBA”). The PPP allows qualifying businesses to borrow up to

$10

million calculated based on qualifying payroll costs. The loan is guaranteed by the federal government, and does

not

require collateral. On

April

30,

2020

we entered into a PPP Loan with Silicon Valley Bank effective

April

30,

2020,

pursuant to the PPP under CARES for

$629,000.

The PPP Loan matures on

April

30,

2022

and bears interest at a rate of

1.0%

per annum. Monthly amortized principal and interest payments are deferred for

six

months after the date of disbursement. The PPP Loan funds were received on

April

30,

2020.

The PPP Loan contains events of default and other provisions customary for a loan of this type. The PPP provides that (

) the use of PPP Loan amount shall be limited to certain qualifying expenses, (

)

100

percent of the principal amount of the loan is guaranteed by the SBA and (

) an amount up to the full principal amount

may

qualify for loan forgiveness in accordance with the terms of CARES. We are

not

yet able to determine the amount that might be forgiven. As of

June

30,

2020,

the Company was in full compliance with all covenants with respect to the PPP Loan. The Company expects to use the full proceeds of the PPP loan in accordance with the provisions of CARES. As of

June 30, 2020,

the balance of the PPP Loan was

$630,000,

which includes

$1.0

thousand in accrued interest.

Future minimum l

oan

obligations consisted of the following at

June 30,

(in thousands):

Period ending June 30,	PPP Loan
2021	$	285
2022		356
2023		—
2024		—
2025		—
Thereafter		—
	$	641
Less Interest*		(11	)
	$	630

XML 28 R18.htm IDEA: XBRL DOCUMENT

Note 12 - Coronavirus Outbreak in the United States	6 Months Ended
Note 12 - Coronavirus Outbreak in the United States	Jun. 30, 2020
Notes to Financial Statements
Contingencies Disclosure [Text Block]	12. Coronavirus Outbreak in the United States Uncertainties surrounding the effects of the coronavirus, particularly potential diversion of time and resources of federal government entities which make up a significant concentration of our customer base, could cause a material adverse effect on our results of operations and financial results. The extent of the impact of COVID- 19 on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, impact on our customers, employees and vendors all of which are uncertain and cannot be predicted. A material disruption in our workplace as a result of the coronavirus could affect our ability to carry on our business operations in the ordinary course and may require additional cost and effort should our employees not be able to be physically on-premises.

XML 29 R19.htm IDEA: XBRL DOCUMENT

Note 13 - Subsequent Events	6 Months Ended
Note 13 - Subsequent Events	Jun. 30, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	13. Subsequent Events. As of the date of this Quarterly Report, all current shares of issued and outstanding preferred stock have been voluntarily converted, resulting in the issuance of a total of 1,004,249 newly issued shares of the Company's common stock. The addition of these newly issued shares has resulted in the dilution of each share of issued and outstanding common stock by a factor of 7.28%. While the elimination of these three classes of preferred stock removes a number of the Company's obligations to the holders of preferred stock (such as the obligation to pay continuing dividends) as well as a number of restrictions on the Company's activities (such as restrictions on certain capital raising and funding transactions), the addition of these newly issued shares combined with the fact that the Company's common stock is thinly traded on the OTCQB Marketplace could cause an increase in selling volume, and result in a decline in the market price of the Company's common stock. On August 6, 2020, Anthony J. LeVecchio was appointed to the board of directors and to serve on the Company's audit and compensation committees.

XML 30 R20.htm IDEA: XBRL DOCUMENT

Significant Accounting Policies (Policies)	6 Months Ended
Significant Accounting Policies (Policies)	Jun. 30, 2020
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10 -Q and Item 10 - 01 of Regulation S- X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The December 31, 2019 balance sheet was derived from audited financial statements, but does not include all the disclosures required by accounting principles generally accepted in the United States. However, we believe that the disclosures are adequate to make the information presented not misleading. In our opinion, all the adjustments (consisting of normal recurring adjustments) considered necessary for fair presentation have been included. The results of operations for the three and six month periods ended June 30, 2020 are not necessarily indicative of the results that may be achieved for the full fiscal year or for any future period. The unaudited condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and notes thereto included in our annual report on Form 10 -K for the year ended December 31, 2019, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 27, 2020.
Fair Value of Financial Instruments, Policy [Policy Text Block]	The Company calculates the fair value of its assets and liabilities which qualify as financial instruments and includes this additional information in the notes to consolidated financial statements when the fair value is different from the carrying value of these financial instruments. The estimated fair value of accounts receivable, accounts payable and accrued expenses, and dividends payable approximate their carrying amounts due to the relatively short maturity of these instruments. Loans payable to officer are with a related party and as a result do not bear market rates of interest. Management believes based on its current financial position that it could not obtain comparable amounts of third party financing, and as such cannot estimate the fair value of the loans payable to officer. None of these instruments are held for trading purposes.
New Accounting Pronouncements, Policy [Policy Text Block]	On January 1, 2019 we adopted ASU No. 2016 - 02, Leases (topic 842 ) . At the date of adoption there was no impact on the statement of operations, while the balance sheet reflects recording both assets and liabilities applicable to the operating right-of-use asset lease identified. ASU No. 2016 - 02 did not have a material effect on the Company's results of operations or cash flows for the three and six month periods ended June 30, 2020 and 2019.

XML 31 R21.htm IDEA: XBRL DOCUMENT

Note 4 - Accounting for Stock-based Compensation (Tables)

6 Months Ended

Jun. 30, 2020

Notes Tables

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

	For Three Months Ended June 30, 2020			For Three Months Ended June 30, 2019			For Six Months Ended June 30, 2020			For Six Months Ended June 30, 2019

Weighted average grant date fair value	$	2.80		$	3.61		$	2.80		$	3.61
Weighted average assumptions used:
Expected dividend yield		0.0	%		0.0	%		0.0	%		0.0	%
Risk-free interest rate		0.43	%		2.19	%		0.43	%		2.19	%
Expected volatility		76.00	%		127.52	%		76.00	%		127.52	%
Expected life (in years)		6.2			5.0			6.2			5.0

XML 32 R22.htm IDEA: XBRL DOCUMENT

Note 10 - Right-of-use Asset and Leasing Liabilities (Tables)

6 Months Ended

Jun. 30, 2020

Notes Tables

Lease, Cost [Table Text Block]

	Three Months Ended				Six Months Ended
	June 30, 20 20		June 30, 201 9		June 30, 20 20		June 30, 201 9
Operating expense:
Amortization expense – Finance ROU	$	11	$	16	$	21	$	32
Lease expense – Operating ROU		82		83		165		162
Other expense:
Interest expense – Finance ROU	$	—	$	1	$	1	$	2

Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block]

	Operating			Finance
Period ending June 30,	ROU Leases			ROU Leases			Total
2021	$	363		$	39		$	402
2022		363			5			368
2023		375			—			375
2024		384			—			384
2025		159			—			159
Thereafter		—			—			—
	$	1,644		$	44		$	1,688
Less Interest*		(183	)		(1	)
	$	1,461		$	43

XML 33 R23.htm IDEA: XBRL DOCUMENT

Note 11 - PPP Loan (Tables)

6 Months Ended

Jun. 30, 2020

Notes Tables

Schedule of Maturities of Long-term Debt [Table Text Block]

Period ending June 30,	PPP Loan
2021	$	285
2022		356
2023		—
2024		—
2025		—
Thereafter		—
	$	641
Less Interest*		(11	)
	$	630

XML 34 R24.htm IDEA: XBRL DOCUMENT

Note 3 - Loan Payable to Officer (Details Textual) - Revolving Credit Facility [Member] - Chief Executive Officer [Member] - USD ($)	6 Months Ended
	Jun. 30, 2020	Oct. 24, 2019	May 31, 2019	Feb. 07, 2019	Feb. 08, 2018
Line of Credit Facility, Maximum Borrowing Capacity		$ 0		$ 2,700,000	$ 3,700,000
Debt Instrument, Basis Spread on Variable Rate	1.00%
Long-term Line of Credit, Total			$ 0

- Definition

The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.

+ References + Details

XML 35 R25.htm IDEA: XBRL DOCUMENT

Note 4 - Accounting for Stock-based Compensation (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)	323,000	24,000	323,000	24,000
Share-based Payment Arrangement, Expense	$ 55,000	$ 10,000	$ 74,000	$ 14,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in shares)	14,000	14,000	186,600	280,500

XML 36 R26.htm IDEA: XBRL DOCUMENT

Note 4 - Accounting for Stock-based Compensation - Valuation Assumptions (Details) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Weighted average grant date fair value (in dollars per share)	$ 2.80	$ 3.61	$ 2.80	$ 3.61
Weighted average assumptions used:
Expected dividend yield	0.00%	0.00%	0.00%	0.00%
Risk-free interest rate	0.43%	2.19%	0.43%	2.19%
Expected volatility	76.00%	127.52%	76.00%	127.52%
Expected life (in years) (Year)	6 years 73 days	5 years	6 years 73 days	5 years

XML 37 R27.htm IDEA: XBRL DOCUMENT

Note 5 - Revenue Recognition (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2020	Dec. 31, 2019
Period of Payment Terms Offered to Customers Distributions and Resellers Domestically (Day)	30 days
Period of Payment Terms Offered to Customers Distributors and Resllers Internationally (Day)	45 days
Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total	$ 1,067,000	$ 1,566,000
Contract with Customer, Liability, Current	$ 164,000	$ 516,000

XML 38 R28.htm IDEA: XBRL DOCUMENT

Note 6 - Net Income (Loss) Per Share (Details Textual) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	1,942,990	12,132	1,909,289	6,066

XML 39 R29.htm IDEA: XBRL DOCUMENT

Note 7 - Concentrations (Details Textual)	3 Months Ended		6 Months Ended
Note 7 - Concentrations (Details Textual)	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020
Number of Areas in Which Operations are Concentrated			1
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| U.S. Government [Member]
Concentration Risk, Percentage	91.00%	91.30%
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Four Government Customers [Member]
Concentration Risk, Percentage	91.00%
Number of Major Customers	4
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Three Government Customers [Member]
Concentration Risk, Percentage		73.20%
Number of Major Customers		3
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| Commercial Customers [Member]
Number of Major Customers	0	0

XML 40 R30.htm IDEA: XBRL DOCUMENT

Note 9 - Dividends Payable (Details Textual)	3 Months Ended
Note 9 - Dividends Payable (Details Textual)	Jun. 30, 2020 USD ($)
Series 1 Preferred Stock [Member]
Dividends, Preferred Stock, Total	$ 13,000
Preferred Stock, Dividend Rate, Percentage	5.00%
Series 2 Preferred Stock [Member]
Dividends, Preferred Stock, Total	$ 13,000
Preferred Stock, Dividend Rate, Percentage	5.00%
Series 3 Preferred Stock [Member]
Dividends, Preferred Stock, Total	$ 7,000
Preferred Stock, Dividend Rate, Percentage	5.00%
Series 2 Preferred Stock and Series 3 Preferred Stock [Member]
Dividends, Preferred Stock, Total	$ 19,000

XML 41 R31.htm IDEA: XBRL DOCUMENT

Note 10 - Right-of-use Asset and Leasing Liabilities (Details Textual) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019	Mar. 31, 2019
Lessee, Finance Lease, Term of Contract (Year)	3 years
Operating Lease, Right-of-Use Asset	$ 1,223		$ 1,348	$ 1,553
Operating Lease, Liability, Total	1,461			$ 1,744
Operating Lease, Payments	$ 179	$ 88
Richardson Property [Member]
Lessee, Operating Lease, Term of Contract (Year)	4 years 244 days
The San Marcos Property [Member]
Lessee, Operating Lease, Term of Contract (Year)	270 days

XML 42 R32.htm IDEA: XBRL DOCUMENT

Note 10 - Right-of-use Asset and Leasing Liabilities - Schedule of Items Appearing on the Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Amortization expense – Finance ROU	$ 11	$ 16	$ 21	$ 32
Lease expense – Operating ROU	82	83	165	162
Interest expense – Finance ROU		$ 1	$ 1	$ 2

XML 43 R33.htm IDEA: XBRL DOCUMENT

Note 10 - Right-of-use Asset and Leasing Liabilities - Future Minimum Lease Obligations (Details) - USD ($)
$ in Thousands

Jun. 30, 2020

Mar. 31, 2019

Operating ROU Leases, 2021

$ 363

Operating ROU Leases, 2022

363

Operating ROU Leases, 2023

375

Operating ROU Leases, 2024

384

Operating ROU Leases, 2025

159

Operating ROU Leases, Thereafter

Operating ROU Leases Undiscounted Obligation

1,644

Operating ROU Leases, Less Interest*

^[1]

(183)

Operating ROU Leases

1,461

$ 1,744

Finance ROU Leases, 2021

Finance ROU Leases, 2022

Finance ROU Leases, 2023

Finance ROU Leases, 2024

Finance ROU Leases, 2025

Finance ROU Leases, Thereafter

Finance ROU Leases Undiscounted Obligation

Finance ROU Leases, Less Interest*

^[1]

(1)

402

368

375

384

159

Lessee, Operating and Finance Lease, Liability, Payments, Due

$ 1,688

[1]	Interest is imputed for operating ROU leases and classified as lease expense and is included in operating expenses in the accompanying condensed consolidated statement of operations.

XML 44 R34.htm IDEA: XBRL DOCUMENT

Note 11 - PPP Loan (Details Textual) - USD ($)		6 Months Ended
Note 11 - PPP Loan (Details Textual) - USD ($)	Apr. 30, 2020	Jun. 30, 2020	Jun. 30, 2019
Proceeds from Issuance of Long-term Debt, Total		$ 629,000
Paycheck Protection Program CARES Act [Member]
Proceeds from Issuance of Long-term Debt, Total	$ 629,000
Notes Payable, Total		630,000
Interest Payable		$ 1,000

XML 45 R35.htm IDEA: XBRL DOCUMENT

Note 11 - PPP Loan - Future Minimum Loan Obligations (Details) - Paycheck Protection Program CARES Act [Member] $ in Thousands	Jun. 30, 2020 USD ($)
2021	$ 285
2022	356
2023
2024
2025
Thereafter
Long-term Debt, Before Expected Interest	641
Less Interest*	(11)
Long-term Debt, Total	$ 630

XML 46 R36.htm IDEA: XBRL DOCUMENT

Note 13 - Subsequent Events (Details Textual) - Subsequent Event [Member]	Aug. 13, 2020 shares
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)	1,004,249
Percentage Dilution from Conversion of Preferred Stock	7.28%

EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
M-8?20$3;8T.P6BP^0"X99K>]9!:G! MND#:]!&@380ZM]N"EL8V$8GT)2DG[=??H02C5%H-NC&]DD4QY-% G#-D7C]I M\[C2^I$]UY6RBV3KW.YJ/+;%%FIA_]$[4/ADK4TM'-Z:S=CN#(C2;@%<78WY M9#(?UT*JY,WKPUBY&8)#_*M&4TD')WFE5@K+=+ZLK M62)1 ,D)2'Y"R.\\@,P(R.R4D%D .24@IZ>$G :0,P)R=DK(60 Y)R#GQX6\ MP^S(4C9B-V +(W>^ ]-K]K:Q4H$-(,\)R/,(D!PAWPHKK4E 7D: G"+D=5'H!G.YVC "[U1\J5O2.$E@G5)DK\ M.D-,2C?ID7W38E[Z+"GW$E-Y:0\K/"2D7),>639='I_X-2,W6S?2ZU%C@5U; MBQ.*7B IVZ11=.-]D^=YFRI#,DHQ:0S'I+S]%(U68B]-8]E]XU:XW7CLK6?* M,FD,S:3>,\MF9>&_QE?F[_=^W82(E&/2(TMF*3%58U_A]PR_/)-CW5/(7DG! M*49W@,SPPM[#XFN;6)X9G>PF9G#SY!VE0S@#I20[NPDQ*?OP&/89JB;[ MWR9E'Q[#/K]7DQA(<$)6(29E(!YCF_/'4@;(H!AK"#(];,O)X+8:%7HBR6SV6/EMS#+*0EF4;<\?RV$?UA"3LE#66FA\.$PO82T5E'_ ]02P,$% @ 9X0-4=;Z^;%X 0 M Q8 !H !X;"]?8_?9U9G)\M.X_$YOS^9J[SR;_KEP=_AAL?YKNY@OG@DF.67=Q86?LO1QO M>SM<:-9/-LGAM#/=X43&Q@YB".+X00)!$C]H#D'S^$$+"%K$#UI"T#)^T J" M5O&#UA"TCA^T@:!-_"!*4<940=($:P5:$W)-"KPF!)L4B$U(-BDPFQ!M4J V M(=NDP&U"N$F!W(1TDP*["?$F!7HSZLT*]&;4FQ7HS9.?;05Z,^K-"O1FU)L5 MZ,VH-RO0FU%O5J WH]ZL0&]&O5F!WHQZLP*]!?46!7H+ZBT*]!;46Q3H+9/# M$@5Z"^HM"O06U%L4Z"VHM[Q3;Q\>I?-CSW.-^[^3ZM"_Z\;MA^7SYN0;'W"V M<.:[_P502P,$% @ 9X0-4>N(NN65 0 @A8 !, !;0V]N=&5N=%]4 M>7!E&ULS9C-;L(P$(1?)^@)ML2$026[:A\/9U MPH_4BD8@*G4NL1+OSHR]TG?(Y'UKR$6;NFK<-"Z\-X^,N;2@6KE$&VK"3JYM MK7QXM0MF5+I4"V)B-!JS5#>>&C_TK48\FSQ3KE:5CUXVX;,K=3.-+54NCIYV MA:W7-%;&5&6J?-AGZR;[X3+<.R2ALZMQ16G<(!3$[*1#N_.[P;[O;4W6EAE% M=YF5*FTU4=6A)G+*G,%42^KI*=Z*#?V8<; MIMV37^W?R?09ALJYU<:%B5FZW.XPDK9[:((065_V'_'H&*2O/A^UT\XH.],[ M7.^GMLMN'HYUR_5W_'W&1_T+Y!T79-: ME&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( &>$#5&#;>@4IP, !@- M 8 " @0X( !X;"]W;W)K)Q0LH& #*'@ & @('K"P M>&PO=V]R:W-H965T&UL4$L! A0#% @ 9X0-4>%#33K' M P L1 !@ ("!ZQ( 'AL+W=O$#5'WKM&+2P4 6 8 " M@>@6 !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0#% @ 9X0-4=D"@Q?B!0 7!8 !@ M ("! ", 'AL+W=O$#5';9RVDG08 "\. 8 " @1@I !X;"]W;W)K&PO=V]R:W-H965T&UL4$L! A0# M% @ 9X0-4>H(0H1J @ * 4 !@ ("!]3, 'AL+W=O M$#5&91][:.00 /4) M 9 " @94V !X;"]W;W)K&UL M4$L! A0#% @ 9X0-42ST*83Q! E0L !D ("!!3L M 'AL+W=O&PO=V]R:W-H965T$#5%PZ=.O0@( 4% 9 M " @8]# !X;"]W;W)K&UL4$L! A0#% @ M9X0-4?UI&'-5 @ $ 4 !D ("!"$8 'AL+W=O&PO=V]R:W-H965T$#5%H MXR37C ( $D% 9 " @;U6 !X;"]W;W)K&UL4$L! A0#% @ 9X0-48N\JZ -! W D !D M ("!@%D 'AL+W=O5MP" !S!@ &0 @('$70 >&PO=V]R:W-H M965T$#5%RW36\)P, (D' 9 M " @==@ !X;"]W;W)K&UL4$L! M A0#% @ 9X0-48$KT^=A @ " 4 !D ("!-60 'AL M+W=O&PO=V]R:W-H965T$#5%TD"L\UP( .P( 9 " M@>!I !X;"]W;W)K&UL4$L! A0#% @ 9X0- M41!\=19' P V0L !D ("![FP 'AL+W=O&PO=V]R:W-H965T$#5&&UL4$L! A0#% @ 9X0-48#8 "82 P A0L M !D ("!(W8 'AL+W=O4WA)J4" !("0 &0 @(%L>0 M>&PO=V]R:W-H965T$#5%SXPFW M,@, @* 9 " @4A\ !X;"]W;W)K&UL4$L! A0#% @ 9X0-40&PO=V]R:W-H965T M$#5%;CJ0==P( *P& 9 M " @:F' !X;"]W;W)K&UL4$L! A0# M% @ 9X0-4012A!NX @ W@< !D ("!5XH 'AL+W=O M&PO=V]R:W-H965T$#5%SK46T)@( -D( - " :>/ M !X;"]S='EL97,N>&UL4$L! A0#% @ 9X0-49>*NQS $P( L M ( !^)$ %]R96QS+RYR96QS4$L! A0#% @ 9X0-4687 M$#5'6^OFQ> $ ,6 : " ;R6 !X M;"]?$#5'KB+KE ME0$ ((6 3 " 6R8 !;0V]N=&5N=%]4>7!E&UL 64$L%!@ L "P ZPL #*: $! end XML 48 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 50 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 65 264 1 true 22 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.intrusion.com/20200630/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.intrusion.com/20200630/role/statement-unaudited-condensed-consolidated-balance-sheets- Unaudited Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.intrusion.com/20200630/role/statement-unaudited-condensed-consolidated-balance-sheets-parentheticals Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Unaudited Condensed Consolidated Statements of Operations Sheet http://www.intrusion.com/20200630/role/statement-unaudited-condensed-consolidated-statements-of-operations Unaudited Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Unaudited Condensed Consolidated Statements of Changes In Stockholders' Equity Sheet http://www.intrusion.com/20200630/role/statement-unaudited-condensed-consolidated-statements-of-changes-in-stockholders-equity Unaudited Condensed Consolidated Statements of Changes In Stockholders' Equity Statements 5 false false R6.htm 005 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.intrusion.com/20200630/role/statement-unaudited-condensed-consolidated-statements-of-cash-flows Unaudited Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Description of Business Sheet http://www.intrusion.com/20200630/role/statement-note-1-description-of-business- Note 1 - Description of Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Basis of Presentation Sheet http://www.intrusion.com/20200630/role/statement-note-2-basis-of-presentation- Note 2 - Basis of Presentation Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Loan Payable to Officer Sheet http://www.intrusion.com/20200630/role/statement-note-3-loan-payable-to-officer- Note 3 - Loan Payable to Officer Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Accounting for Stock-based Compensation Sheet http://www.intrusion.com/20200630/role/statement-note-4-accounting-for-stockbased-compensation Note 4 - Accounting for Stock-based Compensation Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Revenue Recognition Sheet http://www.intrusion.com/20200630/role/statement-note-5-revenue-recognition Note 5 - Revenue Recognition Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Net Income (Loss) Per Share Sheet http://www.intrusion.com/20200630/role/statement-note-6-net-income-loss-per-share Note 6 - Net Income (Loss) Per Share Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Concentrations Sheet http://www.intrusion.com/20200630/role/statement-note-7-concentrations Note 7 - Concentrations Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Commitments and Contingencies Sheet http://www.intrusion.com/20200630/role/statement-note-8-commitments-and-contingencies Note 8 - Commitments and Contingencies Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Dividends Payable Sheet http://www.intrusion.com/20200630/role/statement-note-9-dividends-payable Note 9 - Dividends Payable Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities Sheet http://www.intrusion.com/20200630/role/statement-note-10-rightofuse-asset-and-leasing-liabilities Note 10 - Right-of-use Asset and Leasing Liabilities Notes 16 false false R17.htm 016 - Disclosure - Note 11 - PPP Loan Sheet http://www.intrusion.com/20200630/role/statement-note-11-ppp-loan Note 11 - PPP Loan Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Coronavirus Outbreak in the United States Sheet http://www.intrusion.com/20200630/role/statement-note-12-coronavirus-outbreak-in-the-united-states Note 12 - Coronavirus Outbreak in the United States Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Subsequent Events Sheet http://www.intrusion.com/20200630/role/statement-note-13-subsequent-events Note 13 - Subsequent Events Notes 19 false false R20.htm 019 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.intrusion.com/20200630/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.intrusion.com/20200630/role/statement-note-4-accounting-for-stockbased-compensation 20 false false R21.htm 020 - Disclosure - Note 4 - Accounting for Stock-based Compensation (Tables) Sheet http://www.intrusion.com/20200630/role/statement-note-4-accounting-for-stockbased-compensation-tables Note 4 - Accounting for Stock-based Compensation (Tables) Tables http://www.intrusion.com/20200630/role/statement-note-4-accounting-for-stockbased-compensation 21 false false R22.htm 021 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities (Tables) Sheet http://www.intrusion.com/20200630/role/statement-note-10-rightofuse-asset-and-leasing-liabilities-tables Note 10 - Right-of-use Asset and Leasing Liabilities (Tables) Tables http://www.intrusion.com/20200630/role/statement-note-10-rightofuse-asset-and-leasing-liabilities 22 false false R23.htm 022 - Disclosure - Note 11 - PPP Loan (Tables) Sheet http://www.intrusion.com/20200630/role/statement-note-11-ppp-loan-tables Note 11 - PPP Loan (Tables) Tables http://www.intrusion.com/20200630/role/statement-note-11-ppp-loan 23 false false R24.htm 023 - Disclosure - Note 3 - Loan Payable to Officer (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-3-loan-payable-to-officer-details-textual Note 3 - Loan Payable to Officer (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-3-loan-payable-to-officer- 24 false false R25.htm 024 - Disclosure - Note 4 - Accounting for Stock-based Compensation (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-4-accounting-for-stockbased-compensation-details-textual Note 4 - Accounting for Stock-based Compensation (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-4-accounting-for-stockbased-compensation-tables 25 false false R26.htm 025 - Disclosure - Note 4 - Accounting for Stock-based Compensation - Valuation Assumptions (Details) Sheet http://www.intrusion.com/20200630/role/statement-note-4-accounting-for-stockbased-compensation-valuation-assumptions-details Note 4 - Accounting for Stock-based Compensation - Valuation Assumptions (Details) Details 26 false false R27.htm 026 - Disclosure - Note 5 - Revenue Recognition (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-5-revenue-recognition-details-textual Note 5 - Revenue Recognition (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-5-revenue-recognition 27 false false R28.htm 027 - Disclosure - Note 6 - Net Income (Loss) Per Share (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-6-net-income-loss-per-share-details-textual Note 6 - Net Income (Loss) Per Share (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-6-net-income-loss-per-share 28 false false R29.htm 028 - Disclosure - Note 7 - Concentrations (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-7-concentrations-details-textual Note 7 - Concentrations (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-7-concentrations 29 false false R30.htm 029 - Disclosure - Note 9 - Dividends Payable (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-9-dividends-payable-details-textual Note 9 - Dividends Payable (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-9-dividends-payable 30 false false R31.htm 030 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-10-rightofuse-asset-and-leasing-liabilities-details-textual Note 10 - Right-of-use Asset and Leasing Liabilities (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-10-rightofuse-asset-and-leasing-liabilities-tables 31 false false R32.htm 031 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities - Schedule of Items Appearing on the Statement of Operations (Details) Sheet http://www.intrusion.com/20200630/role/statement-note-10-rightofuse-asset-and-leasing-liabilities-schedule-of-items-appearing-on-the-statement-of-operations-details Note 10 - Right-of-use Asset and Leasing Liabilities - Schedule of Items Appearing on the Statement of Operations (Details) Details 32 false false R33.htm 032 - Disclosure - Note 10 - Right-of-use Asset and Leasing Liabilities - Future Minimum Lease Obligations (Details) Sheet http://www.intrusion.com/20200630/role/statement-note-10-rightofuse-asset-and-leasing-liabilities-future-minimum-lease-obligations-details Note 10 - Right-of-use Asset and Leasing Liabilities - Future Minimum Lease Obligations (Details) Details 33 false false R34.htm 033 - Disclosure - Note 11 - PPP Loan (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-11-ppp-loan-details-textual Note 11 - PPP Loan (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-11-ppp-loan-tables 34 false false R35.htm 034 - Disclosure - Note 11 - PPP Loan - Future Minimum Loan Obligations (Details) Sheet http://www.intrusion.com/20200630/role/statement-note-11-ppp-loan-future-minimum-loan-obligations-details Note 11 - PPP Loan - Future Minimum Loan Obligations (Details) Details 35 false false R36.htm 035 - Disclosure - Note 13 - Subsequent Events (Details Textual) Sheet http://www.intrusion.com/20200630/role/statement-note-13-subsequent-events-details-textual Note 13 - Subsequent Events (Details Textual) Details http://www.intrusion.com/20200630/role/statement-note-13-subsequent-events 36 false false All Reports Book All Reports intz-20200630.xml intz-20200630.xsd intz-20200630_cal.xml intz-20200630_def.xml intz-20200630_lab.xml intz-20200630_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 52 0001437749-20-017830-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-20-017830-xbrl.zip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�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~~U"'3H&Q[#7>*6#F%*BI&EGP M#)R\#6@\7V1DEC,<\+T!9P%*HR#!B(G+*Y(8/8AKG?C:-_08U!BY3T]";?*\ MA\%[&)Y)G*ZP?B6+W.L~~
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end